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Background: Breathlessness is a common and distressing symptom of many advanced diseases, affecting
around 2 million people in the UK. Breathlessness increases with disease progression and often becomes
chronic or refractory. Breathlessness-triggered services that integrate holistic assessment and specialist
palliative care input as part of a multiprofessional approach have been developed for this group, offering
tailored interventions to support self-management and reduce distress.
Objectives: The aim was to synthesise evidence on holistic breathlessness services for people with
advanced disease and chronic or refractory breathlessness. The objectives were to describe the structure,
organisation and delivery of services, determine clinical effectiveness, cost-effectiveness and acceptability,
identify predictors of treatment response, and elicit stakeholders’ evidence-based priorities for clinical
practice, policy and research.
Design: The mixed-methods evidence synthesis comprised three components: (1) a systematic review to
determine the clinical effectiveness, cost-effectiveness and acceptability of holistic breathlessness services;
(2) a secondary analysis of pooled individual data from three trials to determine predictors of clinical
response; and (3) a transparent expert consultation (TEC), comprising a stakeholder workshop and an
online consensus survey, to identify stakeholders’ priorities.
Results: Thirty-seven papers reporting on 18 holistic breathlessness services were included in the systematic
review. Most studies enrolled people with thoracic cancer, were delivered over 4–6 weeks, and included
breathing training, relaxation techniques and psychological support. Meta-analysis demonstrated significant
reductions in the Numeric Rating Scale (NRS) distress due to breathlessness, significant reductions in the
Hospital Anxiety and Depressions Scale (HADS) depression scores, and non-significant reductions in the
Chronic Respiratory Disease Questionnaire (CRQ) mastery and HADS anxiety, favouring the intervention.
Recipients valued education, self-management interventions, and expertise of the staff in breathlessness
and person-centred care. Evidence for cost-effectiveness was limited and inconclusive. The responder
analysis (n = 259) revealed baseline CRQ mastery and NRS distress to be strong predictors of the response
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to breathlessness services assessed by these same measures, and no significant influence from baseline
breathlessness intensity, patient diagnosis, lung function, health status, anxiety or depression. The TEC
elicited 34 priorities from stakeholders. Seven priorities received high agreement and consensus, reflecting
stakeholders’ (n = 74) views that services should be person-centred and multiprofessional, share their
breathlessness management skills with others, and recognise the roles and support needs of informal carers.
Limitations: The evidence synthesis draws predominantly from UK services and may not be generalisable
to other settings. Some meta-analyses were restricted by reporting biases and statistical heterogeneity.
Conclusions: Despite heterogeneity in composition and delivery, holistic breathlessness services are highly
valued by recipients and can lead to significant improvements in the distress caused by breathlessness
and depression. Outcomes of improved mastery and reduced distress caused by breathlessness are not
influenced by patient diagnosis, lung function or health status. Stakeholders highlighted the need for
improved access to person-centred, multiprofessional breathlessness services and support for informal carers.
Future work: Our research suggests that key therapeutic components of holistic breathlessness services
be considered in clinical practice and models of delivery and educational strategies to address stakeholders’
priorities tested.
Study registration: This study is registered as PROSPERO CRD42017057508.
Funding: The National Institute for Health Research (NIHR) Health Services and Delivery programme.
Matthew Maddocks, Wei Gao and Irene J Higginson are supported by the NIHR Collaboration for Leadership
in Applied Health Research and Care (CLAHRC) South London; Matthew Maddocks is supported by a NIHR
Career Development Fellowship (CDF-2017-009), William D-C Man is supported by the NIHR CLAHRC
Northwest London and Irene J Higginson holds a NIHR Emeritus Senior Investigator Award.
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Plain English summary
Over 2 million people in the UK are living with advanced disease and breathlessness, which can occureven when resting or performing everyday activities. Breathlessness can lead to feelings of panic and
anxiety for patients and their family members. Breathlessness is hard to treat and drug treatments are of
limited benefit. Non-drug treatments, such as breathing exercises or using a handheld fan, can often be
used to good effect.
Some services offer a range of drug and non-drug treatments for breathlessness. These have input from
different professional groups. They help patients and families cope with breathlessness by improving
control and reducing distress caused by breathlessness. The aim was to bring together research about
services for people with advanced disease and breathlessness.
First, the research team looked at how services are usually delivered and if they are acceptable, effective
and offer good value for money. It was found that these services are delivered in a variety of ways, but,
overall, they reduce distress caused by breathlessness and reduce depressive symptoms. Patients and carers
particularly valued receiving education, learning simple tips to self-manage their breathlessness and seeing
experts in person-centred care. Information on value for money was very limited and uncertain.
Second, the research team looked at research data from previous studies to find out which people are
most likely to benefit (i.e. experience improvements in feelings of control and distress). It was found that
people presenting with least control, or highest distress, were most likely to benefit. A person’s main
diagnosis, lung function or overall health did affect the likelihood of benefit.
Finally, a meeting was held of patient/carer representatives, researchers and health-care professionals.
The findings above were discussed, and participants shared their priorities for health-care practice, policy
and research. The top suggestions were sent out in a survey. People strongly agreed on seven priorities
around providing flexible, person-centred care, sharing breathlessness management skills among staff and
recognising informal carers.
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Scientific summary
Background
Breathlessness is a common, distressing symptom that affects over two million people in the UK. It
increases as disease progresses and often becomes chronic or refractory (i.e. not responsive to treatment
that is aimed at the underlying disease). It can be frightening for patients and families, and results in
reduced life expectancy and high NHS costs.
There are few effective treatments for refractory breathlessness, which suggests that services that combine
treatments are needed. Cardiac and pulmonary rehabilitation provide exercise-based approaches to help
manage breathlessness, but their reach is limited, particularly with regard to those with the most advanced
disease, who become socially isolated and ‘invisible’.
Holistic breathlessness services provide pharmacological and non-pharmacological treatments to patients
and caregivers, across settings, using multidisciplinary approaches. They emphasise self-management,
and target improvements in quality of life (QoL) by reducing the impact of breathlessness and related symptoms
on everyday living.
Literature scoping identified a body of primary research related to these services, including randomised
controlled trials, but this evidence must be synthesised and understood collectively to inform future
practice. The aim of this study was to synthesise evidence on holistic breathlessness services for people
with advanced disease and chronic or refractory breathlessness.
Objectives
The objectives were to:
l describe the available evidence for holistic breathlessness services in terms of the intervention format,
content, organisation and context, patient characteristics, study design and quality, and outcomes
measured
l determine the clinical effectiveness of holistic breathlessness services on symptom burden, health status
and QoL
l determine the cost-effectiveness of holistic breathlessness services from patient/caregiver, societal and
NHS perspectives
l examine the acceptability of holistic breathlessness services from the perspective of health-care
professions and patients, considering rates of referral, uptake and adherence, as well as patient
experience and satisfaction
l use individual patient data to examine predictors of treatment response, including characteristics of
participants (e.g. level of impairment, symptom burden, multimorbidity) and interventions (e.g. setting,
duration, professional input, delivery)
l use stakeholder consultations to elicit stakeholders’ priorities for clinical practice, policy and research
around holistic breathlessness services, including their role and delivery in relation to cardiac and
pulmonary rehabilitation services.
Methods
Systematic review
Nine databases were searched from inception to 2 June 2017 for qualitative, observational and
experimental studies. Eligibility, methodological quality and reporting quality were independently assessed
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by two authors. Data on service models, health and cost outcomes were synthesised, using meta-analyses
as indicated. The quality of the evidence for each outcome was assessed using the GRADE (Grading of
Recommendations Assessment, Development and Evaluation) approach. Qualitative data on patient/carer
experiences were synthesised thematically. Quantitative experience and patient flow data were tabulated
and/or summarised narratively.
Responder analysis
A secondary analysis was conducted of pooled individual patient data from three trials of holistic breathlessness
services. The primary analysis considered response as a ≥ 0.5-point improvement in the Chronic Respiratory
Disease Questionnaire (CRQ) mastery score, and secondary analysis considered response as a ≥ 1-point
reduction in Numeric Rating Scale (NRS) distress due to breathlessness. Candidate variables included
diagnosis, predicted forced expiratory volume in 1 second (FEV1), baseline CRQ dyspnoea, fatigue, mastery
and emotional domains, EuroQol-5 Dimensions (EQ-5D) Utility Index and visual analogue scale, Hospital
Anxiety and Depression Scale anxiety and depression scores, and NRS average breathlessness in the
previous 24 hours. Variables significantly related to response in univariate logistic regression models were
considered in separate multivariate analyses, comprising backward stepwise logistic regression modelling.
Stakeholder consultation
Transparent expert consultation was used, comprising nominal group technique during a stakeholder
workshop and a follow-up online consensus survey. Stakeholders representing multiple specialties and
professions, as well as patients/carers, were invited to participate in the stakeholder workshop. Following
the presentations covering relevant evidence, participants discussed, and put forward, their own
suggestions for future practice during small group sessions. These suggestions were combined and
synthesised by the project team into a final list of statements, and circulated to a wider group in the online
consensus survey.
The same group of participants, plus additional people from the groups that were under-represented at
the workshop, were invited to participate in the online consensus survey from 12 to 26 February 2018.
Each rated the final statements from 1 (strongly disagree) to 9 (strongly agree), with opportunities for
free-text comments. Scores were analysed descriptively and classified into predetermined categories for
levels agreement and consensus.
Results
Systematic review
Of 3239 records identified, 37 papers were included, representing 18 different services. Most services
enrolled people with thoracic cancer, involved palliative care staff and comprised 4–6 contacts over
4–6 weeks. Common interventions were breathing techniques (14/18), psychological support (12/18) and
relaxation techniques (11/18).
Meta-analyses demonstrated reductions in distress due to breathlessness [n = 324; mean difference (MD)
–2.30, 95% confidence interval (CI) –4.43 to –0.16; p = 0.03] and depression scores (n = 408; MD –1.67,
95% CI –2.52 to –0.81; p < 0.001), favouring the intervention. Statistically non-significant effects were
observed for breathlessness mastery (n = 259; MD 0.23, 95% CI –0.10 to 0.55; p = 0.17) and anxiety
scores (n = 552; MD –1.59, 95% CI –3.22 to 0.05; p = 0.06). There was no observable effect on overall
health status or QoL. Evidence for cost-effectiveness was limited to four studies and was inconclusive.
Patients reported a high level of satisfaction with services. In particular, patients and their informal carers
valued the provision of dignified, person-centred care from expert staff; education and information-sharing;
and useful self-management interventions that were simple and portable (e.g. handheld fan, breathing
techniques).
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Responder analysis
The pooled data set comprised 259 participants (118 female) with a mean age of 69.2 [standard deviation
(SD) 10.6] years. The most common primary diagnosis was chronic obstructive pulmonary disease (49.8%),
followed by cancer (34.7%) and interstitial lung disease (10.4%), with a mean FEV1% predicted value of
46.2 (SD 21.4).
Controlling for age, sex and trial in the multivariate modelling, baseline CRQ mastery remained the only
significant predictor of intervention CRQ mastery response [odds ratio (OR) 0.57, 95% CI 0.43 to 0.74;
p < 0.001], and baseline NRS distress remained the only significant predictor of intervention NRS distress
response (OR 1.64, 95% CI 1.35 to 2.03; p < 0.001).
Stakeholder consultation
Stakeholders attending the workshop (n = 37) produced 34 statements reflecting their priorities: 10 for
clinical practice, 8 for policy and 16 for research. Following ratings by 74 online survey respondents, seven
had strong agreement and a high level of consensus.
Stakeholders’ priorities for clinical practice were to:
l ensure that breathlessness services are person-centred and flexible in terms of delivery (e.g. appointment
location, time, and duration)
l ensure that breathlessness services are cross-cutting, drawing on relevant expertise from multiple
disciplines, professions and providers
l work towards ensuring that breathlessness services have the widest possible geographical coverage and
access (e.g. travelling communities, people who are homeless, people living in care/nursing homes)
l acknowledge family and/or informal carers within breathlessness services and, when appropriate,
actively encourage their participation in education and in management of the patient’s breathlessness
l value symptom management in its own right, and be able to deliver (or refer patients for)
breathlessness interventions
l share breathlessness management skills with other health and social care professionals, and informal carers.
Stakeholders’ priority for health-care policy was to recognise informal carers in terms of their role,
importance and support needs.
Conclusions
Holistic services for chronic or refractory breathlessness in people with advanced disease are heterogeneous
in their components and delivery, but are acceptable to patients and carers, who value the tailored
education, simple and portable breathlessness self-management interventions and psychological support
provided in the services. Overall, these services lead to significant improvements in psychological aspects of
breathlessness and health. The evidence for cost-effectiveness of these services is inconclusive.
Clinical response to holistic breathlessness services in terms of increased mastery or reduced distress is
influenced by baseline scores for these variables, but not by breathlessness severity, patient diagnosis, lung
function, health status, anxiety or depression. In the context of limited resources, prioritising patients with
low levels of mastery or high levels of distress could be appropriate to direct resources to those most likely
to benefit.
Stakeholders showed strongest agreement and consensus around suggestions to improve access to
person-centred, multiprofessional care, and support for carers to provide, or access, breathlessness
management interventions. Future research in this field should test the optimal models of care and
educational strategies to address stakeholders’ priorities and understand how best to embed core
therapeutic components into routine clinical practice.
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Chapter 1 Introduction
Chronic breathlessness
Breathlessness (also known as shortness of breath or dyspnoea) is a subjective experience around breathing
discomfort that varies according to the sensation and intensity.1,2 The experience is shaped by multiple
interacting factors (i.e. physiological, psychological, social and environmental) and can lead to secondary
physiological and behavioural responses.1,2
Terminology and classification of breathlessness are evolving (Table 1). The terms ‘breathlessness’ and
‘dyspnoea’ are internationally recognised, but their definition does not reflect the nature of breathlessness
that is persistent despite optimal disease management. Similarly, ‘episodic’ breathlessness has been used
to highlight important spells of breathlessness that often drive hospital use,17 but with less emphasis on
its often chronic duration. Terms such as ‘intractable’ and ‘refractory’ breathlessness better capture this
feature of breathlessness and how challenging it can be to manage, but can also suggest a complete
resistance to treatment, which is not always the case. More recent consensus work16 has since developed a
definition of ‘chronic’ breathlessness that better reflects the impact on patient experience and disability,
in addition to persistence despite optimal disease management.
Given the lack of universal consensus, we use ‘chronic or refractory breathlessness’ in this evidence
synthesis. In line with the recent consensus work, this reflects the impact of breathlessness that persists
despite optimal management on patients, while also highlighting its relentless nature and how challenging
it can be to manage.
Chronic or refractory breathlessness is one of the most common, burdensome and neglected symptoms
affecting patients with advanced malignant and non-malignant conditions.16,18,19 It affects over 2 million
people in the UK, including up to 98% of the 1 million people diagnosed with moderate to severe chronic
lung disease,20–22 more than half of the ≥ 200,000 people with incurable cancer, 70% of those with lung
cancer,23 and half of the 2 million people with chronic heart failure.23–26 Breathlessness is also found in
people with end-stage renal and liver disease, neurological diseases, human immunodeficiency virus
(HIV)/acquired immunodeficiency syndrome (AIDS) and many autoimmune diseases.23–26 The number of
people affected by breathlessness will rise globally with population ageing and increasing multimorbidity.27
TABLE 1 What’s in a name: emerging and common definitions of chronic, refractory and episodic breathlessness
Term Definition
Breathlessness or dyspnoea2 A subjective experience of breathing discomfort that consists of qualitatively
distinct sensations that vary in intensity
Intractable breathlessness3 Breathlessness that persists despite treatment of the disease
Refractory breathlessness4,5 Breathlessness that persists despite optimal treatment of the underlying condition
Chronic breathlessness6 Episodes of breathlessness lasting > 3 months
Chronic refractory breathlessness7–9 Chronic breathlessness that is refractory to treatments for the underlying condition
Episodic breathlessness10–14 Severe worsening of breathlessness intensity or unpleasantness beyond usual
fluctuations13–15
Chronic breathlessness syndrome16 Breathlessness that persists despite optimal treatment of the underlying
pathophysiology and results in disability for the patient
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Breathlessness can be very frightening for patients and families25,26,28–31 and can have a devastating impact
on their lives, severely limiting well-being and quality of life (QoL).2,32–34 It is associated with considerable
anxiety, depression, fear, social isolation, deconditioning and disability,21,28,29,31,35,36 and shortened life
expectancy.37–39 The experience of breathlessness is often compounded by multiple and interacting
symptoms including cough, pain, fatigue, anxiety and depression.25,26,33,36,40,41 For informal carers of people
with breathlessness, it can result in disrupted sleep, high levels of stress and caregiver burden,29 fewer
positive caring experiences,29 and feelings of being isolated, unsupported by health-care professionals,
and ill-prepared for acute exacerbations.31,35,42,43 The experience of chronic breathlessness tends to increase
as the disease progresses;44,45 therefore, it can function as a marker of overall symptom burden and
deterioration.25,46,47
Current treatment and service provision
Chronic breathlessness is one of the most frequent causes of emergency department attendance and
prolonged hospital admission, and results in high health, social and informal care costs.28,29,36,48–52 It was
estimated that the total annual cost of respiratory disease in the UK was £11B in 2014, representing
approximately 9% of the total economic burden of illness.53 Despite this, there remain few effective
treatments for chronic breathlessness, making it a major challenge in improving palliative and end-of-life
care.18,54–57
There are limited pharmacological treatments for chronic breathlessness43,58 and there are currently no
licensed medicines for the treatment of this symptom anywhere in the world.2,59–62 Systematic reviews
of effectiveness and clinical trials are available for opioids, oxygen and benzodiazepines.3,62–67 Orally
administered opioids have been found to be beneficial in the treatment of breathlessness in patients with
advanced disease, but the effects are modest or small61,62 and there are concerns regarding adverse cardiac
and respiratory effects of long-term use, especially in older people with chronic obstructive pulmonary
disease (COPD).68–71 Oxygen has a clear and accepted role in treating mildly hypoxic patients.72–74 However,
the benefit derived from oxygen in mildly or non-hypoxaemic breathless patients is similar to medical air,
and there are limitations to its use (e.g. safety, cost).67,75,76 Benzodiazepines have been found to have no
beneficial effect, with some evidence of possible harm.58,65 Although there are patient case reports of the
effectiveness of antidepressants to treat chronic breathlessness, controlled trials are lacking.77–79 Both the
European Respiratory Society (ERS) and the American Thoracic Society have concluded that there
is not a robust evidence base for other pharmacological agents beyond oxygen and opioids.2,59 In addition,
pharmacological treatments do not address the underlying psychosocial problems, which also perpetuate
the symptom.80
Breathlessness can be effectively managed via non-pharmacological treatments that incorporate exercise,
education and behavioural interventions.81–83 Pulmonary or cardiac rehabilitation, a multidisciplinary
programme of care comprising exercise-training and education (particularly around self-management) is
widely known to improve symptom burden, functional status, physical fitness and health-related QoL.81,82
However, for those with advanced disease, there are issues with referral, limited uptake and ability to
sustain engagement because of social isolation, difficulties with travel, health deterioration, impeding
symptoms and potential stigma.4,28,54,84,85 Therefore, it is important to explore interventions that may work
alongside, as a bridge to or, for some, as an alternative to rehabilitation interventions, whereby outcomes
may be supported via alternative mechanisms.
Holistic breathlessness services
In response to these challenges with chronic breathlessness management, holistic breathlessness services
have emerged for people with advanced disease.86–88 There is no consensus on the definition of holistic
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breathlessness services; however, as complex interventions, these services can be described in terms of
their setting, structure and content. Core features of holistic breathlessness services include:
l drawing on multiple specialties, typically with input from multiprofessional palliative care (e.g. doctors,
physiotherapists) with or without respiratory medicine, cardiology or oncology
l delivery by multidisciplinary team members (e.g. physicians, nurses and allied health professionals)
l use of both pharmacological and non-pharmacological therapies, selected following a holistic
assessment of individual patient and caregiver needs (physical, psychological, social and spiritual)
l emphasising self-management, through use of education and behaviour change techniques
l targeting improvements in patient and caregiver QoL by reducing the impact of breathlessness and
related symptoms on everyday living.
Holistic breathlessness services can be offered in community, outpatient or day hospice settings, and there
is variation in the extent to which families or informal carers receive direct support.
Individual studies have reported positive outcomes from these services for patients and carers including
higher levels of patient satisfaction, improved self-reported breathlessness mastery, and reduced patient
distress, health-care contacts and need for informal care, without increasing the overall cost to the UK
NHS.89–95 One study also suggested a potential survival advantage.94 Alongside this, international guidelines
have advocated early integration of palliative care for people experiencing chronic disease,96,97 for which
chronic and/or distressing breathlessness could be a suitable indicator for referral (particularly in non-cancer
conditions in which prognostication causes delays54). Yet the evidence base to inform policy and practice is
poorly understood.
Scoping and need for evidence synthesis
A scoping search was undertaken to identify the size, nature and range of existing evidence relating to holistic
breathlessness services, and this informed the design of the evidence synthesis. In the decade following a
positive report from a randomised controlled trial (RCT) of a nurse-led service published in 1999,98 evidence
relating to these services was minimal and generally of low quality because it was limited to uncontrolled
service evaluations. More robust evidence has emerged in recent years, underscoring the interest and relevance
of this topic to health and social care. A scoping search from 2005 onwards identified four RCTs,91,94,95,99,100
as well as a number of prospective cohort studies,101,102 qualitative studies,103–107 narrative reviews or opinion
pieces3,7,18,108–122 and consensus statements.2,56,123,124 No systematic reviews have assessed the clinical effectiveness
or cost-effectiveness of these services. Although not exhaustive, the scoping exercise highlighted the need for an
evidence synthesis of holistic breathlessness services, to inform clinical practice, policy and research in the future.
Aim and objectives
This project aimed to provide a comprehensive and objective summary of the current available evidence for
the clinical effectiveness and cost-effectiveness of holistic breathlessness services for people with advanced
malignant and non-malignant disease.
The research objectives were to:
l describe the available evidence for holistic breathlessness services in terms of the intervention format,
content, organisation and context, patient characteristics, study design and quality, and outcomes
measured
l determine the clinical effectiveness of holistic breathlessness services on symptom burden, health status
and QoL
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l determine the cost-effectiveness of holistic breathlessness services from patient/caregiver, societal and
NHS perspectives
l examine the acceptability of holistic breathlessness services from the perspective of health-care
professionals and patients, considering rates of referral, uptake and adherence, as well as patient
experience and satisfaction
l using individual patient data, examine predictors of treatment response, including characteristics of
participants (level of impairment, symptom burden, multimorbidity) and interventions (setting, duration,
professional input, delivery)
l using stakeholder consultation, elicit stakeholders’ priorities for clinical practice, policy and research
around holistic breathlessness services, including their role and delivery in relation to cardiac and
pulmonary rehabilitation services.
Research group
This project was led by the Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation at King’s
College London (KCL), with the following collaborating institutions: University of East Anglia, Royal
Brompton & Harefield NHS Trust, University of Cambridge and King’s College Hospital NHS Foundation Trust.
The project advisory group (PAG) included a consortium of international leaders and clinical academics in
palliative care and respiratory and rehabilitation research, as well as patient and carer representatives:
l Dr Matthew Maddocks (Senior Lecturer in Health Services Research and Specialist Physiotherapist, KCL)
l Professor Irene J Higginson [Professor of Palliative Care and Policy, Scientific Director of Cicely Saunders
International and National Institute for Health Research (NIHR) Senior Investigator, KCL]
l Ms Lisa Jane Brighton (Research assistant, KCL)
l Dr Wei Gao (Senior Lecturer in statistics and epidemiology, KCL)
l Dr Deokhee Yi (Health Economist, KCL)
l Dr Sabrina Bajwah (Consultant and honorary senior lecturer, KCL)
l Dr Sara Booth (Honorary Consultant and Associate Lecturer, University of Cambridge)
l Dr Morag Farquhar (Senior Lecturer, University of East Anglia)
l Dr William D-C Man (Senior Lecturer/Consultant Chest Physician, Imperial College London)
l Dr Charles Reilly (Consultant Physiotherapist, King’s Health Partners)
l Ms Lucy Fettes (Specialist Physiotherapist, St Joseph’s Hospice and KCL)
l Ms Alanah Wilkinson (Research Administrator, KCL)
l Dr Nicholas Hart (Clinical and Academic Director Lane Fox Respiratory Service, Guy’s & St Thomas’ NHS
Foundation Trust/Professor in Respiratory and Critical Care Medicine)
l Ms India Tunnard (Research Administrator, KCL)
l Dr Sophie Miller (Specialty Training Registrar, St Christopher’s Hospice)
l Mr Daniel Marion (patient/carer representative)
l Ms Lesley Turner (patient/carer representative)
l Mrs Colleen Ewart (patient/carer representative)
l Mr Gerry Bennison (patient/carer representative)
l Ms Margaret Ogden (patient/carer representative)
l Mrs Sylvia Bailey (patient/carer representative).
Any changes to the protocol were reported to and approved by the PAG.
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Chapter 2 Evidence synthesis methods
This project comprised an evidence synthesis of published and unpublished data through systematicreview and a secondary analysis of pooled individual patient trial data, undertaken in conjunction with
a transparent stakeholder consultation.
Systematic review methods
The systematic review considered quantitative, qualitative and economic studies to examine the clinical
effectiveness, cost-effectiveness and acceptability of holistic breathlessness services.
Design and registration
The systematic review and meta-analyses were conducted and reported in accordance with the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement,125 and adhered to
guidelines from the Centre for Reviews and Dissemination and Methodological Expectations of Cochrane
Intervention Reviews. The review protocol was prospectively registered with PROSPERO (reference number
CRD42017057508).126
Eligibility criteria
The following inclusion criteria were applied.
l Participants: adults experiencing breathlessness related to advanced disease (described as suffering from
breathlessness, dyspnoea, shortness of breath, difficulty breathing, laboured breathing and with advanced
stages of diseases with a high prevalence of breathlessness) including, but not limited to, cancer (advanced
local or metastatic), chronic respiratory disease [Global initiative for chronic Obstructive Lung Disease
(GOLD) stage III or IV/grade C or D], heart failure (New York Heart Association stage III or IV) or progressive
neurological conditions. Studies in which ≥ 50% of participants met these definitions were included.
l Interventions: as there is no standard definition, holistic breathlessness services were defined as services
that draw on multiple specialties and disciplines, encompass pharmacological and non-pharmacological
interventions selected on the basis of a holistic needs assessment, enrol patients because of their
breathlessness (not their diagnosis), emphasise self-management, aim to reduce the perception and impact
of breathlessness and related symptoms, and are offered in outpatient, community or day hospice settings.
l Comparators: all comparators were considered for controlled studies, including no treatment, usual
care, an attention control (e.g. a patient support group without a specific focus on breathlessness) or an
active control (e.g. alternative service).
l Outcomes: health outcomes included breathlessness intensity; breathlessness affect and impact;2 anxiety
and depression; physical functioning; health status or QoL; and survival. Economic outcomes included
formal health and social care service utilisation and costs, unpaid caregiver costs including caregivers’
time off work, quality-adjusted life-years (QALYs) derived from generic QoL measures [e.g. EuroQol-5
Dimensions (EQ-5D)] and perspectives of economic analysis. Acceptability outcomes included patient
flow data (uptake, adherence, completion), as well as patient and caregiver perspectives on acceptability,
satisfaction and/or experience.
l Study design: RCTs with a parallel, single-stage or cross-over design, including studies using minimisation,
non-randomised studies including prospective and retrospective designs, quantitative and qualitative
designs to elicit patient and caregiver satisfaction and experience.
Studies were excluded if they did not specifically target patients with breathlessness, or if interventions that
targeted breathlessness used only a single treatment (e.g. physical exercise). Pulmonary rehabilitation and
disease-specific services (e.g. integrated respiratory care) were deemed outside the scope of this review.
Interventions that exclusively targeted service providers or carers were also excluded. Narrative reviews,
opinion papers, case studies and case series with fewer than five participants were excluded.
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Search strategy
Electronic searches
The following electronic databases were searched from their respective inceptions up to 2 June 2017:
l British Nursing Index (1985)
l Cumulative Index to Nursing and Allied Health Literature (CINAHL) (1980)
l Cochrane Database of Systematic Reviews (CDSR)
l Cochrane Central Register of Controlled Trials (CENTRAL)
l Database of Abstracts of Reviews of Effects (DARE)
l EMBASE (1980)
l MEDLINE (1966)
l PsycINFO (1985)
l Science Citation Index Expanded (1985).
The search terms and strategy were developed and piloted with information specialists to ensure broad
inclusivity. They were informed by literature scoping, MEDLINE medical subject heading terms and subject
filters within specific databases. Subject headings and free-text terms were combined to search for
population and intervention terms. The MEDLINE search strategy is shown in Appendix 1.
Hand-searching
To identify additional studies, reference lists of retrieved studies and relevant editorials and reviews,
citations, textbooks and voluntary sector materials were searched. We contacted the corresponding
authors of retrieved studies and active researchers to identify unpublished data or grey literature arising
from meetings or conference proceedings. No language or publication status restrictions were imposed in
the selection of evidence reports.
Screening of studies
Potentially eligible reports were imported into bibliographic software Endnote X7 [Clarivate Analytics
(formerly Thomson Reuters), Philadelphia, PA, USA] and duplicates removed. Two researchers (SM and
LJB/MM) independently screened all titles and abstracts for relevance, and independently assessed full texts
of potentially eligible studies for compliance with the review criteria. Disagreements were resolved by
discussion between the screening team and wider team, until consensus on eligibility was reached.
Quality assessment
All included studies were independently assessed by two researchers (LJB and MM) for methodological and
reporting quality, using standardised checklists, as outlined below. Information to aid quality assessment
was obtained from primary, secondary and protocol articles.
Methodological quality
The Standard Quality Assessment Criteria for Evaluating Primary Research Papers (QualSyst)127 was used
to assess the methodological quality of all studies. QualSyst contains two checklists with accompanying
manuals to guide systematic quality assessment of quantitative and qualitative studies. For mixed-method
studies, both checklists were used for the relevant component of the study and supplemented with three
items that were specific to this design from the Mixed Methods Appraisal Tool.128 Scores were summarised
as a percentage score of applicable items.
Randomised controlled trials were also assessed for risk bias using the Cochrane Collaboration’s tool,129
which considers six domains: sequence generation, allocation concealment, blinding of study participants
and personnel, completeness of outcome data, selective reporting, and other potential sources of bias.
A judgement was made for the level of risk of bias (i.e. low, high or unclear) for each domain.
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Methodological quality assessments of economic evaluations were informed by the British Medical Journal
checklist for authors and peer-reviewers of economic submissions.130 Thirty-five items in study design, data
collection and analysis and interpretation of results were marked as yes, no, or not clear.
Reporting quality
Established checklists were used to assess the quality of reporting (Table 2).
Quality of the evidence
The quality of the body of evidence for each clinical outcome was rated independently by two members
of the research team (MM/LJB and MF) using the GRADE (Grading of Recommendations Assessment,
Development and Evaluation) approach,135 which considers study limitations, consistency of effect, imprecision,
indirectness and publication bias. The final grade was reviewed by additional members of the PAG.
We decreased the grade if there was:
l serious (–1) or very serious (–2) limitation to study quality
l important inconsistency (–1)
l some (–1) or major (–2) uncertainty about directness
l imprecise or sparse data (–1)
l a high probability of reporting bias (–1).
The following grades of evidence categories were then assigned for each outcome:
l high – further research is very unlikely to change our confidence in the estimate of effect
l moderate – further research is likely to have an important impact on our confidence in the estimate of
effect and may change the estimate
l low – further research is very likely to have an important impact on our confidence in the estimate of
effect and is likely to change the estimate
l very low – any estimate of effect is very uncertain.
Data synthesis/data extraction and analysis
Data on the characteristics of the service, outcomes and study information were extracted from each paper
by one researcher (SM/LJB) using a predesigned electronic data capture form. These were checked by a
second researcher to ensure rigour (LJB/MM). Authors were contacted if additional information was needed
for meta-analyses. To increase validity and ensure comprehensiveness, the analysis and interpretation were
reviewed by members of the PAG including researchers, patient/carer representatives and clinicians.
TABLE 2 Tools for assessing reporting quality
Study design Tool(s) to assess reporting quality
RCTs CONSORT statement131
Pilot/feasibility trials CONSORT extension for pilot and feasibility studies132
Quasi-experimental Adaptation of CONSORT statement using applicable items
Observational STROBE statement133
Qualitative COREQ checklist134
Mixed methods COREQ plus the most appropriate quantitative checklist
CONSORT, Consolidated Standards of Reporting Trials; COREQ, COnsolidated criteria for REporting Qualitative research;
STROBE, Strengthening the Reporting of Observational Studies in Epidemiology.
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Structure, organisation and delivery/service characteristics
We described the overall content and organisational aspects of services to appraise the degree of
consistency or heterogeneity.136 Data on service characteristics were tabulated with details of the
associated studies, including the intervention setting (i.e. home, community, hospital), duration of service
involvement and frequency of patient contact, team members by profession/specialty, patient diagnoses,
and component interventions. Component interventions were tabulated and summarised narratively.
Clinical effectiveness and cost-effectiveness
Only data from controlled studies were included to estimate effectiveness. Outcomes were analysed as
continuous data when possible. Mean differences (MDs) or standardised mean differences between
intervention and comparator groups were reported with 95% confidence intervals (CIs). When there were
sufficient data and consistent or comparable outcomes, a meta-analysis was performed using random-effects
models to estimate the overall direction, size and consistency of effects. Clinical heterogeneity assessed
using the I2 statistic to quantify inconsistency across studies and the impact on the meta-analysis.137 Separate
sensitivity analyses were conducted excluding studies with a high risk of bias (< 70% QualSyst score), and
removing outliers when substantial heterogeneity (I2 > 75%138) was present. In all cases, individual studies
were represented only once within each analysis. We planned funnel plots to assess publication if ≥ 10 studies
were included.139 Additional findings were summarised narratively.
For health economic data, we planned to present types of economic analyses; describe the population,
setting and intervention; present effect size and cost-effectiveness results for the high-quality economic
evaluations;130 and perform a quantitative synthesis if sufficient data were available.
Patient acceptability and experience
Data were extracted on patient and caregiver perspectives on acceptability, satisfaction and/or experience,
as well as process data regarding patient flow (including rates of referral, uptake, adherence to intervention
and completion).
For qualitative or mixed-methods studies, all text (including quotations) under the headings of ‘results’ or
‘findings’ were imported verbatim into qualitative data analysis software [NVivo v12 (QSR International,
Warrington, UK)]. A thematic synthesis of qualitative data involved three consecutive steps: (1) line-by-line
coding of results of all included studies, (2) development of descriptive themes, incorporating themes or
codes of primary studies, with particular attention to similarities and differences across and between
studies and (3) new development of analytical themes, going beyond presentation of the original data.140
The final coding frame was reviewed by members of the PAG with a variety of backgrounds (e.g. research,
clinical, patient/carer representatives) to increase interpretive rigour. Findings from the quantitative surveys
and patient flow data were tabulated and/or summarised narratively.
Responder analysis methods
Design
To identify patient characteristics that predict response to holistic breathlessness services, in terms of
patient breathlessness mastery and distress due to breathlessness, we conducted a secondary analysis of
pooled individual patient data from three RCTs.91,94,95 These were a convenience sample of available data
through project team members who were involved with, and act as, data custodians for these trials.
As a result of collaborations during the trial designs, there was also a high number of variables in common
across these data sets to aid pooling.
Data sources and ethics approvals
Trials included Higginson et al.’s94 2014 trial of a 6-week service with people with advanced disease,
Farquhar et al.’s91 2014 trial of a 2-week service for people with advanced cancer and Farquhar et al.’s95
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2016 trial of a 4-week service for people with non-malignant disease. Participants in each trial had chronic
or refractory breathlessness and advanced disease.
Anonymised individual patient data were obtained from the data custodians, and data sets were cleaned
and harmonised. This secondary analysis of anonymised data did not require ethics approval. Each of the
contributing studies followed appropriate ethics approval procedures (King’s College Hospital reference
number 10/H0808/17; Cambridgeshire 2 NHS reference number 08/H0308/157).
Methods
Our study built on methods of a previous analysis of patient predictors of response to opioids.141 The
primary analysis considered an intervention response on Chronic Respiratory Disease Questionnaire (CRQ)
mastery, defined by the minimal clinically important difference as an improvement of 0.5.142 This outcome
was selected as it was the primary outcome for the Higginson et al.94 study, and a secondary outcome in
the Farquhar et al.91,95 studies.
The secondary analysis considered an intervention response on Numerical Rating Scale (NRS) distress due
to breathlessness (henceforth, NRS distress), defined as an improvement of 1 point.143 This was selected for
secondary analysis as it was the primary outcome for both Farquhar et al.91,95 studies, but not measured in
the Higginson et al.94 study.
Candidate variables (and their reference group/possible score ranges) for the primary and secondary
analysis included diagnosis (reference group: COPD); predicted forced expiratory volume in 1 second
(FEV1) and baseline scores for CRQ dyspnoea; CRQ fatigue; CRQ mastery and CRQ emotional function
(1 to 7); EQ-5D Utility Index (–1 to 1) and EQ-5D visual analogue scale (VAS) (0 to 100); Hospital Anxiety
and Depression Scale (HADS) anxiety and HADS depression (0 to 21); and NRS average breathlessness in
the last 24 hours (0 to 10; henceforth, NRS average). As it was not measured in Higginson et al.,94 baseline
NRS distress (0 to 10) could be included only in the secondary analysis. For all variables, the time point
immediately pre intervention for each group was treated as ‘baseline’ (e.g. in the Higginson et al.94 trial,
fast-track participants’ baseline was week 1, wait-list participants’ baseline was week 6).
Variables deemed significantly related to response (p < 0.05) in univariate logistic regression models were
included in the multivariate analyses. Multivariate analyses comprised backward stepwise logistic regression,
in which variables with the largest non-significant (p > 0.05) p-value in the model were sequentially removed.
Dependent variables were assessed for multicollinearity. To control for age, sex (reference group: male) and
study of origin (refence group: Farquhar et al.95), these variables were forced into the multivariate analyses.
To aid interpretation, variables that were significant predictors of response were categorised (when
possible, using previously established groupings for that measure). The percentages of participants classified
as responders for each baseline category were then tabulated.
Transparent expert consultation methods
Design
Nominal group techniques are commonly used for consultation with stakeholders, but have been criticised
for lacking transparency, reliability and opportunities for clarification.93 Although the Delphi technique
overcomes these issues, this method can be time-consuming with multiple rounds of consultation, and the
initial content can be shaped by a minority. Transparent expert consultation (TEC) methods have, therefore,
been developed in response to these limitations,93,144 and have been successfully used to elicit recommendations
in palliative and end-of-life care research.145–149
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Our TEC comprised a stakeholder consultation and follow-up online consensus survey. Like nominal group
technique, the stakeholder workshop provided structured opportunities for expression of views by a group
of experts. This activity was followed by a wider online consensus survey to rate the suggested priorities
(similar to a single-round Delphi technique), enabling rapid consultation of multiple key stakeholders.
Participants
A wide range of stakeholders involved in the provision of care for people with chronic breathlessness
were purposively selected and invited to participate in the stakeholder workshop. Service providers and
commissioners, voluntary sector organisation representatives, patient and carer representatives, and health
and social care practitioners from a range of specialties and professional groups were identified through
contact lists of people and organisations that the research team had previously worked with, online
literature and website searches, and via recommendations from participants.
The PAG members, workshop participants and those who expressed interested but were unable to attend
the stakeholder workshop, were invited to complete the online consensus survey. Additional individuals
from groups that were under-represented at the workshop (including service users) were also purposively
invited to complete the consensus survey, using the methods described above. All participants were adults
with capacity to give informed consent.
Ethics, recruitment and informed consent
Ethics approval for this study was obtained from the KCL research ethics committee (reference number
LRS-16/17-4692).
A personal e-mail invitation to the stakeholder workshop was sent to purposively selected stakeholders,
including a copy of the information sheet, the consent form and the workshop schedule (see Appendix 2).
This provided an opportunity for attendees to consider the study information prior to the day of the
workshop, at which time they were asked to provide written consent prior to the recorded discussions and
data collection. Participants were reimbursed reasonable travel costs to attend the stakeholder workshop.
For the online survey, information regarding its purpose and how the data would be used was included in
an attachment to the invitation e-mail and summarised at the start of the survey. Consent for the online
survey was presumed through participation. A hard-copy postal consensus survey with a freepost return
envelope was available to participants preferring that format.
Procedure
Identifying critical questions
The findings of the systematic review around the service components, clinical effectiveness, cost-effectiveness
and acceptability of holistic breathlessness services for people with chronic breathlessness in advanced
disease were used to generate critical questions for consideration during the stakeholder workshop. Through
discussion of the review findings with the PAG, three critical questions were identified:
1. How do we define and deliver ‘holistic breathlessness services’?
2. How and where can holistic breathlessness services be integrated into current practice?
3. How should the success of holistic breathlessness services be measured/monitored?
Transparent expert consultation workshop
The TEC workshop took place at the Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation,
KCL, on October 4 2017. Participants received a pack on arrival containing the information sheet, consent
form and schedule for the day.
The workshop format began with whole-group presentations and discussion. The first of these presented
results from the systematic review, including data on the make-up or services, common components,
EVIDENCE SYNTHESIS METHODS
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preliminary quantitative outcome data and qualitative data on the acceptability of breathlessness services.
In addition, evidence was presented by experts on rehabilitation services, care bundles, and supporting
informal carers of people with chronic breathlessness (see Appendix 2).
In parallel groups, workshop participants considered one of the three critical questions identified from the
review. Participants were allocated to groups to ensure diversity of experience and roles within each. These
sessions used a nominal group technique, facilitated by members of the research team using a structured
process developed before the workshop (Table 3). This included completion of individual response booklets
to gather individual thoughts and suggestions. Parallel-group sessions were also audio-recorded, and
scribes recorded the top priorities on flip chart paper for each parallel group and to share with the wider
group.150 A live graphic recording of the whole-group and parallel-group discussions was created by an
artist who was present throughout the event. The workshop closed with a summary of the day and
information about the follow-on online consensus survey.
The materials generated from the discussions throughout the day were reviewed and summarised into
main themes by one researcher (LJB), including those from whole-group discussions and each parallel
group. This was primarily based on the written notes, with reference to the recording when further
clarification was needed. The narrative summary of salient and common points was reviewed by members
of the research team to ensure an accurate and transparent reflection of the workshop discussions.
Online consensus survey
Participants’ suggestions generated from the workshop, their rational, ranking and grouping, were
anonymised and entered in a Microsoft Excel® (Microsoft Corporation, Redmond, WA, USA) spreadsheet.
Two members of the research team (LJB, MM) categorised the statements as relevant to clinical practice,
research or policy. For instances in which participants felt that a suggestion was relevant to more than
one category, it was assigned to the predominant category. Statements were ranked from most to least
important, as reported by participants.
After multiple readings of the material, statements were synthesised and deduplicated. Stakeholders’
suggestions were not retained if they were deemed to be duplicates of other statements generated in
this exercise, redundant (e.g. research studies known to have been conducted), unclear, outside the
scope (e.g. not specific to chronic breathlessness in advanced disease) and/or ranked as low priority by the
participant who wrote it. The graphic and audio-recordings, scribes’ notes and flip chart records were
referred to when clarification was needed. Statements retained participants’ original language whenever
possible, with amendments only to enhance clarity and avoid inflexible statements (e.g. changing ‘must’
to ‘could’).145,147
TABLE 3 Structured process for workshop groupwork
Step Process
Written responses Participants wrote individual answers to ‘prompt questions’ in response booklets. These were
tailored to the critical question each group was focusing on, for example ‘What are the core
components of a holistic breathlessness service?’ (group 1); ‘Where should a holistic breathlessness
service be based?’ (group 2); and ‘What is the ideal set of outcomes to measure for patients?’ (group 3)
Initial reflections Reflections from this exercise in relation to the critical question were then discussed
Individual suggestions Participants wrote individual suggestions for future practice in their response booklets, with a
rationale and indication of relevance for clinical practice, policy and/or research
Ranking Participants were asked to rank each of their own suggestions from highest to lowest
Discussion Participants in turn read out their highest ranked suggestions and rationale, which were discussed
by the group. This continued until individual lists were exhausted or time was exceeded149
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The final list of participants’ suggestions was discussed and refined with the PAG, before being formatted
into an online survey. Within the survey, three sets of participants’ suggestions relevant to research, clinical
practice and policy were presented, and respondents were asked to indicate their level of agreement
with each statement from 1 (strongly disagree) to 9 (strongly agree). Survey respondents were given the
opportunity for free-text comments in each section and asked to select their profession/role and area(s)
of expertise, with a free-text ‘other’ option if required.144,149,151 The survey was piloted by clinical, research
and patient representative members of the PAG to ensure that it was clear and user-friendly.
The survey ran for a period of 2 weeks, from 12 to 26 February 2018. Potential participants were sent a
personalised e-mail invitation, followed by two reminders, to complete the online consensus survey.
Analysis
Survey responses were analysed using descriptive statistics [frequencies, median, interquartile range (IQR),
range]. Predetermined categories from previous TECs were used to determine levels of agreement and
consensus146,147 (Table 4). Narrative comments were collated within each category and thematically
analysed to aid understanding and provide illustrative examples of the issues raised by stakeholders’
suggestions.152
Patient and public involvement
In addition to the patient and public involvement (PPI) collaborators involved with the original grant
application, four additional members were identified and invited to join the research team via the Cicely
Saunders Institute Patient and Public Involvement Group. All were given an informal ‘role description’ to
introduce them to the Institute, the project and our intentions for PPI.
The aim of PPI throughout this project was to ensure acceptable and appropriate research processes where
patient/carers would be participating, include patient/carer voices throughout our consultation with
stakeholders, ensure interpretation of findings were grounded in patient/carer experiences, and improve
clarity and reach of dissemination.
The PPI involvement in this study used a mixture of face-to-face methods (e.g. inclusion in project advisory
meetings) and remote methods (e.g. via telephone and e-mail). Involvement was flexible, with each
member being more or less involved at different points in the study, in line with their availability and/or
TABLE 4 Classification of agreement and consensus on participants’ statements
Median IQR Category
≥ 8 < 2 Strong agreement/high consensus
≥ 8 ≥ 2 Strong agreement/low consensus
< 8 to > 6 < 2 Moderate agreement/high consensus
< 8 to > 6 ≥ 2 Moderate agreement/low consensus
≥ 4 to ≤ 6 < 2 No agreement/high consensus
≥ 4 to ≤ 6 ≥ 2 No agreement/low consensus
< 4 to > 2 < 2 Moderate disagreement/high consensus
< 4 to > 2 ≥ 2 Moderate disagreement/low consensus
≤ 2 < 2 Strong disagreement/high consensus
≤ 2 ≥ 2 Strong disagreement/low consensus
EVIDENCE SYNTHESIS METHODS
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current health. The PPI members were included as members of the project team and invited to all project
advisory meetings. They were invited to comment on the plain English summary and study plans,
with a particular focus on recruiting PPI members for the TEC and ensuring acceptability of the workshop
and online survey methods. They were involved in commenting on study findings, considering the meaning
of results, and write-up and dissemination of materials and reports.
We reimbursed PPI members’ expenses and time, in accordance with NIHR INVOLVE guidance.153 PPI members
were supported by the research assistant as a key contact throughout their involvement. At the end of
the study, we reflected on PPI involvement using the Guidance for Reporting Involvement of Patients and
the Public 2 (GRIPP2) short form and sought feedback from the PPI members in order to share learning from
our experiences.
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Chapter 3 Systematic review results
Following screening of 3239 unique titles/abstracts and 56 full papers, 37 papers were eligible forinclusion in the review (see Appendix 3 for the PRISMA flow chart). Included papers were published
between 1996 and 2017 (27 since 2010) and relate to 18 separate holistic breathlessness services:
12 based in the UK, three in Canada and one each in Australia, Germany and Hong Kong. Thirty-three
articles were included in the descriptive synthesis (see Appendix 4).
Data from 12 studies (11 RCTs90,91,94,95,98–100,154–157 and one quasi-experimental design156) of seven different
services were included in the quantitative synthesis (see Appendix 4 for a description of all included studies).
Five RCTs were designed as pilot/feasibility studies,90,99,155,157 and seven as effectiveness studies.91,94,95,98,100,154,155
Nine studies90,91,95,98,155–158 compared the services to usual care, and two compared one versus three contacts
with a service.99,100 In one study,90 the control group were not offered training or counselling, but were
encouraged to talk freely about their breathlessness and disease.
Nine studies enrolled only cancer patients,90,91,98–100,155–157 two enrolled only patients with non-malignant
disease95 or COPD,154 and one study enrolled patients with any advanced disease.94 Of the 979 total
patients recruited (range 2299 to 156100), there were 757 (77.3%) with advanced cancer and 180 (18.4%)
with advanced COPD; the remaining participants (4.3%) had other non-malignant diseases, including
interstitial lung disease or heart failure. The controlled studies assessed a wide variety of outcome
measures (see Appendix 5), the most common being breathlessness intensity,89,90,94,99,154–158 distress due to
breathlessness,90,91,95,98,99,155–158 and anxiety and depression.90,91,94,95,98,155–157
The thematic synthesis included qualitative and quantitative experience data. Qualitative data were from
five services, reported across 12 papers,88,90,91,94,95,102–105,159–161 (six mixed-method studies90,91,94,95,102,103,161 and
five qualitative studies88,104,105,159,160) (see Appendix 4). Almost all data were from interviews with patients
and/or carers,88,90,91,94,95,102,104,105,159,160 except for one using free-text responses to a postal survey103 and one
using therapist notes.161 Altogether, this included data from 167 patients (53.9% with cancer) and up to
49 carers. Quantitative data around satisfaction with, or experiences of, the services were reported in
seven studies, which represented the views of 543 patients (60.77% with cancer).99,100,103,157,161,162,168
Study quality
Quality assessment scores for the studies included in the quantitative synthesis ranged from 35% to 100%
(median 90.4%; see Appendix 6). Studies for which only an abstract was available received lower
scores.154–156 All studies were deemed at risk of detection bias and most at risk of performance bias, owing
to the nature of the intervention that prohibited patient blinding and relied on primarily self-assessed
outcomes (see Appendix 7). Just three studies reported blinding of investigators.91,94,95
Quality assessment scores for qualitative studies ranged from 40% to 85% (median 70%; see Appendix 8).
The majority of studies had clear descriptions of their objectives, with an appropriate design including
methods that were clear and systematic. However, the common limitations within the qualitative studies
included lack of procedures to establish credibility of the data (e.g. triangulation, member checking), and
unclear reporting of the analytic methods. Moreover, none of the included studies demonstrated reflexivity
in their reports by reflecting on the impact of the researchers’ own personal characteristics on the data.
For the mixed-methods studies (n = 7), quality assessment items showed that, although this design was
always clearly appropriate for the aims of the study, few (n = 2) reflected on the potential limitations of
integrating qualitative and quantitative data (see Appendix 9).
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For studies containing economic evaluations (n = 4), quality scores ranged from 64% to 77%. Commonly
low-scoring items included having a clear statement and justification for the economic viewpoint,
information on the evaluation method used, and a discussion around the relevance of productivity changes
(see Appendix 10).
Reporting quality
Reporting quality overall was reasonably high for RCTs and pilot/feasibility trials, and generally poorer for
quasi-experimental and qualitative studies (Table 5).
Across all the experimental designs, there was limited reporting around harms and unintended consequences,
or reflection on generalisability of the study findings. For RCTs and quasi-experimental studies, it was
often not explicitly stated whether or not important changes had been made to methods and outcomes,
or what their processes were for interim analysis and/or stopping guidelines. For quasi-experimental studies,
few reported specific objectives or hypotheses, or clarified their primary and secondary outcomes. In the
pilot/feasibility studies, papers often failed to define the methods and assessment measures for each study
objective, or the criteria they used to judge whether or not to proceed with a definitive trial.
Papers scored with the qualitative reporting checklist were mainly mixed-methods reports, and only three
were purely qualitative papers. Information frequently missing included details of the researcher and
interviewer, contextual factors surrounding interviews (e.g. prior relationships between researchers and
participants, and whether or not others were present during the interview), and elements with the
potential to increase rigour (e.g. whether or not field notes were made, and whether or not participants
commented on the transcripts and/or findings). These papers also tended not to report interview durations
or full coding trees and did not reflect on data saturation or diverse cases/minor themes.
In all cases, papers published prior to the reporting checklists tended to score lower. For full reporting
quality scores for each study design, see Appendix 11.
TABLE 5 Reporting quality for full papersa
Study design Reporting quality checklist
Papers
assessed (n)
Score median
(%)
Score range
(%)
RCTs CONSORT statement131 5 81 53–92
Pilot/feasibility trials CONSORT extension for pilot and feasibility
studies132
4 71 31–79
Quasi-experimental Adaptation of CONSORT statement using
applicable items
4 52 35–73
Observational STROBE statement133 1 84 –
Qualitative COREQ checklist134 10 46 22–68
CONSORT, Consolidated Standards of Reporting Trials; COREQ, COnsolidated criteria for REporting Qualitative research;
STROBE, Strengthening the Reporting of Observational Studies in Epidemiology.
a Full results papers (i.e. not protocols, abstracts, or letters) were assessed for reporting quality.
Mixed-methods studies were assessed with COREQ and the most appropriate quantitative checklist.
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Service characteristics
Services were delivered by doctors, nurses, physiotherapists and occupational therapists, with involvement
from the specialisms of palliative care, respiratory care and oncology. Most services (12/18) were short term
and usually delivered to people with advanced cancer over a period of 4–6 weeks (range 1–12 weeks)
via a mixture of face-to-face and telephone contacts (typically 4–6 contacts, range 1–12 contacts; see
Appendix 5).
Services incorporated a wide range of intervention components, including information and education,
psychosocial support, self-management strategies and other interventions (Table 6). Components most
commonly included in services were breathing techniques (14/18), psychological support (12/18) and
relaxation or calming techniques (11/18). A minority of services (≤ 2/18) included acupressure or
transcutaneous electrical nerve stimulation, spiritual support, information on sleep hygiene and smoking
cessation advice or support.
TABLE 6 Service components
Intervention n Servicesa
Information and education
Education/advice 9 90,94,95,157,162–166
Nutritional advice/support 3 95,164,167
Sleep hygiene 2 95,168
Smoking cessation advice/support 1 95
Written information 4 94,95,164,166
Psychosocial support
Carer/family support 5 90,94,95,162,166
Psychological support 12 90,94,95,101,154,156,161,162,164–167
Social support 7 90,94,95,154,156,164,166
Spiritual support 1 94
Self-management strategies
Breathing techniques 14 90,94,95,100,101,154,156,157,161,163,164,166,168,169
Emergency/crisis planning 3 94,95,166
Exercise plans 5 94,95,164,166,170
Handheld fan/water spray 5 94,95,101,164,166
Goal-setting 4 90,95,101,166
Pacing 8 94,95,100,101,161,164,166,167
Positioning 4 94,95,164,166
Relaxation/calming techniques 11 90,94,95,100,101,154,161,164,166,167,169
Other interventions
Acupressure/transcutaneous electrical nerve stimulation 2 157,170
Occupational aids 5 94,95,164,166,170
Pharmacological review 4 94,95,168,169
a One citation per service.
Reproduced with permission from Brighton et al.92 This is an open access article distributed in accordance with the Creative
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Clinical effectiveness
Breathlessness severity
Ten studies90,94,98–100,154–157 assessed the severity of breathlessness using one or more of the following measures:
VAS, NRS or Borg scores (Table 7). For ‘best breathlessness’, two studies using VAS found a greater
improvement in the intervention group than in the control (differences in median change 5.7, p = 0.03,98
and 1.0, p = 0.02),90 and three studies with unspecified measures found a significant intervention effect
[F(2,44) = 5.30; p = 0.009]156 or no difference (data not reported).155,156 For ‘worst breathlessness’, one study
using VAS found a greater improvement in the intervention group than in the control (difference in median
change 3.5; p = 0.05),90 whereas no significant differences were found by two studies using NRS (MD –0.35,
95% CI –1.71 to 1.01; p = 0.61;94 MD 0.41, 95% CI –0.86 to 1.67; p = 0.53),157 one study using VAS
(difference in median change 3.8; p = 0.14)98 and one with an unspecified measure155 (data not reported).
For ‘average breathlessness’, one study using an unspecified measure found a greater improvement in the
intervention group than in the control (difference in mean change 1.2),155 whereas two studies using
NRS did not (MD –0.33, 95% CI –1.28 to 0.62; p = 0.49;94 MD 0.65, 95% CI –0.49 to 1.80; p = 0.26).157
One study using NRS found no effect on breathlessness on exertion (MD –0.73, 95% CI –1.69 to 0.22;
p = 0.13)94 and one study using Borg scale ratings for breathlessness at rest and on exertion found no
difference between groups (data not reported).154 In line with their feasibility study results,99 a powered trial
comparing one with three service contacts found no significant difference in NRS worst (MD 0.2, 95% CI
−2.31 to 2.97; p = 0.83) or average (MD 0.3, 95% CI –2.00 to 2.62; p = 0.79) breathlessness.158
Breathlessness affect
Ten studies90,91,95,98–100,155–157 assessed ‘distress due to breathlessness’ using VAS (range 0–100,
higher = worse) or NRS (range 0–10, higher = worse).91,95 Eight of these studies compared breathlessness
services to usual care, three of which155,156 reported no significant difference but did not provide data. Data
from five studies90,91,95,98,157 were combined in a meta-analysis (n = 324; Figure 1) that showed significantly
lower NRS distress following the intervention than following the control (MD –2.30, 95% CI –4.43 to
–0.16; p = 0.03). A sensitivity analysis excluding two outlier studies90,98 resulted in a reduced point estimate
of effect and non-significant difference (MD –0.29, 95% CI –1.00 to 0.43; p = 0.43; I2 = 0%). Similar to
the finding from the preceding feasibility study,99 a RCT testing service variations found no difference on
NRS ‘coping with breathlessness’ (MD –1.7, 95% CI –4.27 to 0.90; p = 0.20),100 and significantly higher
NRS distress due to breathlessness following three sessions versus one session (MD 3.9, 95% CI 0.98 to
6.91; p = 0.01).100
The quality of evidence for distress due to breathlessness was rated as very low. Owing to the lack of
blinding of participants or outcome assessors, plus evidence of (or unclear information regarding) attrition
bias, the evidence was downgraded for risk of bias. This evidence was also downgraded for inconsistency
(owing to wide variation in effect estimates across studies), and imprecision (evidenced by wide variance in
point estimates and lower 95% CIs, indicating potentially very little effect).
Four studies91,94,95,154 assessed ‘mastery over breathlessness’ using the CRQ mastery domain.94,154 A meta-analysis
of these data (n = 259; Figure 2) showed a statistically non-significant increase in mastery (range 1–7,
higher = better) favouring the intervention (MD 0.23, 95% CI –0.10 to 0.55; p = 0.17). A sensitivity analysis
excluding one study,154 deemed to be at a high risk of bias, increased the point estimate of effect (MD 0.30,
95% CI –0.06 to 0.66; p = 0.11). One study found significantly lower mastery scores after three service
contacts than after one service contact (MD –0.6, 95% CI –1.06 to –0.11; p = 0.02).100
One further study found improved dyspnoea-12 (range 0–36; higher = worse) scores with the intervention
than with control (MD 5.19, 95% CI 0.62 to 9.75; p = 0.026).157
We judged the quality of evidence for mastery to be low. This evidence was downgraded because we
deemed the studies to have a high risk of bias due to the lack of blinding of participants or outcome
SYSTEMATIC REVIEW RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
18
TABLE 7 Measures of breathlessness severity in controlled studies
Descriptor Scale Timeframe
Studies
Barton
et al.99
Bredin
et al.98
Corner
et al.90
Higginson
et al.94
Johnson
et al.158
aPearce
et al.154
aYates
et al.156
aYates
et al.155
Yorke
et al.157
Best VAS Previous week ✗
Unknown ✗
Unknown Unknown ✗ ✗
Worst VAS Previous week ✗
Unknown ✗
NRS Previous
24 hours
✗ ✗ ✗ ✗
Unknown Unknown ✗
Average NRS – ✗ ✗ ✗
Previous
24 hours
✗
Unknown Unknown ✗
On exertion Borg – ✗
NRS Previous
24 hours
✗
At rest Borg – ✗
Now NRS – ✗
a Abstract only.
Reproduced with permission from Brighton et al.92 This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which
permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of
whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
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assessors, plus the evidence of (or unclear information regarding) attrition bias. In addition, we
downgraded this evidence for imprecision because of the wide variance in point estimates and lower
95% CIs, indicating potentially very little effect.
Psychological outcomes
Seven studies assessed anxiety and depression using HADS.90,91,94,95,98,155,157 Data from these seven studies
(n = 552, Figure 3) showed a statistically non-significant reduction in anxiety scores (range 0–21;
higher = worse), favouring the intervention (MD –1.59, 95% CI –3.22 to 0.05; p = 0.06). The sensitivity
analysis, excluding one study155 deemed to be at a high risk of bias, increased the point estimate (–1.85,
95% CI –3.76 to 0.06; p = 0.06). A sensitivity analysis removing one outlier study98 resulted in a reduced
point estimate but statistically significant group difference (MD –0.66, 95% CI –1.23 to –0.10; p = 0.02;
I2 = 0%). No statistical differences in anxiety were reported when comparing one and three contacts.99,100
We rated the quality of evidence for anxiety to be very low. This evidence was downgraded because of
the risk of bias, including the lack of blinding of participants or outcome assessors, plus the evidence
of (or unclear information regarding) attrition bias. We also downgraded for inconsistency (owing to
wide variation in effect estimates across studies), and imprecision (evidenced by wide variance in point
estimates, and lower 95% CIs indicating potentially very little effect).
For depression, one study156 reported no difference between groups but did not provide data. Meta-analysis
using the six remaining studies (n = 408, Figure 4) showed reduced depression scores (range 0–21,
higher = worse) favouring the intervention (MD –1.67, 95% CI –2.52 to –0.81; p < 0.001). No statistical
differences in depression were reported when comparing one and three contacts.99,100
The quality of evidence for depression was judged to be moderate. This evidence was downgraded for risk
of bias only, indicated by the lack of blinding of participants or outcome assessors, plus the evidence of
(or unclear information regarding) attrition bias.
Three further studies reported no significant differences between the intervention and control groups in
‘psychological symptoms’: two using an unspecified measure (data not reported)155,156 and one using the
Rotterdam Symptom Checklist (range 7–28, higher = worse; difference in median change –8; p = 0.21).98
One study comparing one session with three sessions found no significant difference on CRQ emotion
scores (MD –0.09, 95% CI –0.54 to 0.36; p = 0.69).100
Physical function and health status/quality of life
Five studies90,91,94,95,98 assessed physical function. Two studies found greater improvements following the
intervention than in the control participants using the Functional Capacity Scale (range 0–14; higher = better;
MD for change 1.25; p < 0.02)90 and World Health Organization (WHO) Performance Status Scale (range 0–5,
higher = worse; difference in median change 2, p = 0.02).98 Three studies observed no difference in functional
outcomes between groups assessed using the London Chest Activities of Daily Living Scale (MD –5, 95% CI
–12.22 to 1.02; p = 0.10)94 or patient-reported number of times leaving their house (data not reported).91,95
Seven studies91,94,95,98,100,154,157 included a measure of health status or QoL, none of which found significant
differences between groups across the CRQ dyspnoea domain91,94,95,154 (including the comparison between
one and three sessions100) or total score,94 EQ-5D index94 or VAS,94,157 and the Rotterdam Symptom Scale
QoL domain.98 Owing to heterogeneous measures, change from baseline and post-intervention scores,
and cases of non-normally distributed data, we decided against meta-analysis for these outcomes.
Survival
Two studies reported survival data.94,98 One found a significant difference in survival (generalised Wilcoxon
score of 3.9; p = 0.048) in favour of the intervention.94 Subgroup analysis found that the difference was
driven by participants with non-cancer diagnoses. The remaining study, enrolling only patients with cancer,
found no difference in survival across groups (data not reported).98
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Carer outcomes
Two studies91,95 assessed outcomes for carers of patients using the service. No significant differences were
reported between groups on carer anxiety (HADS) or depression (HADS) or distress due to the patient’s
breathlessness (NRS).
Cost-effectiveness
Economic evaluation
Evidence for cost-effectiveness of the interventions was limited and non-conclusive. Four studies of three
services were eligible for inclusion,91,94,95 and all used GBP 2011/12 costs. Three studies compared the
service with usual care, and one study compared offering one session with offering three sessions within
a service.
The perspective of the analysis for Farquhar et al.’s91 study of their Breathlessness Intervention Service (BIS)
was societal by including costs of informal care. Among patients with advanced cancer, total health/social
costs including informal care for 8 weeks prior to the baseline assessment were £6137 [standard deviation
(SD) £6099] in the BIS group and £5461 (SD £6099) in the usual care group. Costs between baseline and
follow-up at 2 weeks were £794 (SD £866) for BIS and £1121 (SD £1635) for usual care. Intervention costs
for the BIS were £119 (SD £62). Total costs were £354 lower for the BIS than for usual care (95% CI
–£1020 to £246) and incremental QALY gain was 0.0002 (95% CI –0.001 to 0.002) after controlling for
baseline. The chance of the BIS having lower total costs and resulting in a greater QALY gain than usual
care was 80.9% according to cost-effectiveness planes. There was a 50.9% chance of the BIS being lower
than usual care for total costs, and having a greater number of QALYs.
For Farquhar et al.’s95 study of their BIS, a NHS perspective was used. Among patients with advanced
non-malignant disease, total health/social costs for 8 weeks prior to the baseline assessment were £1952
(SD £3290) in the BIS group and £3630 (SD £5588) in the usual care group. Costs between baseline and
follow-up at 4 weeks were £1371 (SD £2948) for BIS and £659 (SD £1253) for usual care. Intervention
costs for BIS were £156 (SD £80). After adjusting for baseline values, total costs were £799 higher for BIS
(95% CI –£237 to £1904) and the BIS group gained 0.003 extra QALYs (95% CI –0.001 to 0.007) than
the control group. The cost per QALY for BIS was £266,333. The chance of BIS having lower total costs and
resulting in a greater QALY gain than usual care was 7% according to cost-effectiveness planes.
Higginson et al.’s94 Breathlessness Support Service (BSS) was assessed in terms of hospital inpatient days
and formal care costs for 12 weeks prior to the baseline assessment. The cost of formal care was £2911
(SD £2729) for BSS and £3709 (SD £4484) for usual care. Incremental QALY gain between baseline and
follow-up at 6 weeks was 0.092 (95% CI –0.23 to 0.04). No more information related to economic
evaluation was reported in this paper, but a separate paper51 analysed the same data to measure the cost
of care, regardless of randomisation. The total cost for all participants was £11,507 (SD £9911), which was
the sum of health-care costs [£2624 (SD £3456)], social care costs [£628 (SD £1132)] and informal care costs
[£8254 (SD £8777)]. Increased breathlessness on exertion was associated with higher health-care costs and
informal care costs, and having a carer was associated with higher informal care costs.
Johnson et al.’s158 trial compared one session with three sessions of a breathlessness service from a NHS
perspective, including costs of the service in each arm and other health-related resource use costs. For the
three-session service, there was a non-significant reduction in overall QALYs (MD –0.006, 95% CI –0.018
to 0.006) and non-significant increase in costs. There was no evidence that the additional costs were offset
by lower health-related resource use costs elsewhere. The probability of the single session being cost-effective
at a threshold value of £20,000 per QALY was > 80%.100
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Referral, uptake, adherence and adverse events
Of the 11 RCTs included in the analysis, fewer than half reported numbers screened for eligibility. When
available, studies reported screening between 53 and 932 people for eligibility, of whom 15% to 48.6%
were deemed to be eligible for inclusion. The total number of participants randomised into each trial
ranged from 22 to 156. Of the participants randomised, between 50% and 90.8% of participants
completed the trial to key outcome stages. Full data including reasons for attrition are described in Table 8.
No adverse events were reported.
Experiences
Across the 11 studies with qualitative data90,91,94,95,102–106,159–161 and the five studies with quantitative
data99,100,103,157,161,162,168 on participants’ satisfaction, three themes emerged with regard to experiences:
valued characteristics, perceived outcomes and challenges to services.
Satisfaction
Five studies assessed overall satisfaction with their service. For one service, 18 out of 21 respondents (86%)
stated that they would recommend the clinic that they attended to another breathless patient;168 for
another service, 100% of patients reported high satisfaction and would recommend the service.103 One
study reported high patient satisfaction with care but data were not provided.162 When comparing one
versus three sessions with a service, satisfaction with care was higher for those receiving three sessions in
the feasibility study (data not provided),99 but there was little difference between the groups in the full trial
(MD 0.4).100
Valued characteristics
Participants valued the education and information-sharing included in the services, particularly in terms
of helping them understand their breathlessness, legitimising the interventions being suggested, and
providing helpful written resources to refer to (Box 1). The interventions themselves (e.g. techniques for
breathing, pacing, positioning, relaxation and using a handheld fan) were praised for their simplicity,
portability and perceived effectiveness. The psychosocial support received through the services was
also highly valued, providing opportunities for participants to have their experiences listened to and
acknowledged, to receive support and reassurance, and to discuss problems beyond their breathlessness.
Participants’ comments also indicated their appreciation of carers involvement, both to support carers as
individuals and to support them in caring for the patient. Overwhelmingly, participants commented on the
qualities of the staff delivering the services: they were deemed experts not only in managing breathlessness,
but also in providing person-centred care and treating participants with respect and dignity.
Studies that collected quantitative data on the most helpful characteristics of services also reflected these
valued characteristics: one study found that talking to a therapist was rated as most helpful, followed
by breathing exercises, relaxation techniques and positive thinking;161 another study’s participants felt
that the breathing techniques were helpful;157 and a third study found that the leaflets (e.g. managing
breathlessness, distraction techniques, positioning techniques, handheld fan information), handheld fan
and discussions of crisis management provided at the clinic were most helpful.103 Of the interventions
provided at home, the most helpful were breathing exercises, breathlessness management, relaxation
techniques and energy conservation information. The interventions that were reported as not helpful by
breathless patients included acupuncture,157 bronchodilators, massage and ‘not fighting it’.161
Perceived outcomes
In line with quantitative findings on clinical effectiveness, perceived positive outcomes reported in the
qualitative data were largely psychological (Box 2). Participants reported an increased understanding of
their breathlessness and disease, in a way that normalised their experiences. As a result, participants
reported feeling more confident in managing their breathlessness, and it reduced their anxieties and
distress. In particular, knowing that breathlessness would not cause death and that they had tools to
respond to it was encouraging.
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TABLE 8 The RCT referral, uptake, adherence and adverse events
Study authors and year Screened (n)
Eligible,
n (%) Reasons for ineligibility/exclusion Randomised (n)
Completed
(post intervention),
n (%) Adherence
Barton et al. 201099 53 22 (41.5) Ineligible included 13 undergoing
chemotherapy/radiotherapy,
5 declined, 5 too unwell,
4 prior breathlessness training,
2 unconfirmed malignancy, 1 not
breathless, 1 cause of breathlessness
treated
22 11 (50.0) Of 11 allocated to the three-session
intervention, 5 dropped out by the fourth
assessment (2 died, 2 declined, 1 too unwell).
Of the 11 allocated to the single-session
intervention, 6 dropped out by the fourth
assessment (3 died, 2 too unwell, 1 declined)
Bredin et al. 199998 NR 119 16 patients excluded because of a
protocol violation (one centre failed
to adhere to the trial protocol and
so was excluded on advice of data
monitoring committee)
103 60 (58.3) Of the 52 allocated to the control, 3 refused
study after randomisation, 15 withdrawn,
7 died. Of the 51 allocated to intervention,
1 refused study after randomisation,
8 withdrew, 9 died. Of the total 27 who
withdrew but did not report an improvement
in their breathlessness, 16 withdrew because
of deteriorating condition (13 control,
3 intervention) and 4 were unhappy with
the arm allocated (3 control, 1 intervention).
This left 7 who withdrew for other reasons
(2 control, 5 intervention)
Corner et al. 199690 NR NR 34 patients had consented to take
part in the randomised study when
randomisation was stopped in
response to requests from medical
and nursing staff who felt that they
had observed a clear benefit from the
intervention strategy
34 20 (58.8) Of the 19 allocated to intervention and 15 to
control, 14 patients withdrew because of
deterioration (8 and 6, respectively)
Farquhar et al. 201491 NR 158 81 eligible patients agreed to
recruitment visit, 14 of whom died
or were withdrawn by service/
researcher/patient
67 54 (80.6) Of the 35 allocated to intervention, 7 were
lost to study (5 condition deteriorated, 2 died).
Of the 32 allocated to control, 6 were lost to
study as their condition deteriorated
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TABLE 8 The RCT referral, uptake, adherence and adverse events (continued )
Study authors and year Screened (n)
Eligible,
n (%) Reasons for ineligibility/exclusion Randomised (n)
Completed
(post intervention),
n (%) Adherence
Farquhar et al. 201695 NR 159 97 eligible patients agreed to
recruitment visit, 10 of whom died
or were withdrawn by service/
researcher/patient
87 79 (90.8) Of the 44 allocated to intervention, 3 were lost
to study (including 1 death) by time point 3
(conducted 4 weeks after baseline). Of the
43 allocated to control, 5 were lost to study
(including 1 death) by time point 3
Higginson et al. 201494 216 105 (48.6) 11 did not meet inclusion criteria
and an additional 100 were not
randomised for other reasons
(6 died at time of referral letter
receipt, 29 declined to participate,
18 were too ill to participate,
47 unable to be contacted)
105 82 (78.1) 53 were allocated to intervention and 52 to
control. By week 6, 4 died (1 intervention,
3 control), 5 withdrew (no reason)
(2 intervention, 3 control), 8 withdrew
because of illness (4 intervention, 4 control),
and 6 were unable to be contacted
(patient often hospitalised or moved away)
(4 intervention, 2 control). Attrition to primary
outcome was lower than estimated (22% not
40%) and so recruitment was stopped at 105
Johnson et al. 2015158 932 156 (16.7) Of the 776 excluded from enrolment,
127 had insufficient shortness of
breath, 528 declined (no reason),
38 were unable to give informed
consent, 32 had comorbidities/
intercurrent illness, 22 required
urgent medical intervention, 20 had
previous pulmonary rehabilitation,
and 9 had other reasons
156 124 (79.5) 52 were allocated to the three-session
intervention and 104 to the single-session,
but only 39 and 91 received their respective
allocated intervention because 2 from each
group withdrew prior; a further 11 did not
receive the three-session intervention (2 too
unwell, 1 only well enough to receive some,
8 no reason); and another 11 did not receive
the single-session [1 did not attend (lost to
follow up), 8 no reason, 1 deteriorated
before, 1 not reported]
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Study authors and year Screened (n)
Eligible,
n (%) Reasons for ineligibility/exclusion Randomised (n)
Completed
(post intervention),
n (%) Adherence
Yorke et al. 2015157 715 107 (15.0) Of the 608 ineligible, 176 had
absence of two or more symptoms
or did not have bothersome
breathlessness, 40 had poor
prognosis, 55 had further treatment,
130 had recent chemotherapy,
128 had other reasons, 74 declined
and 5 were reason unknown
107 72 (67.3) Of the 53 allocated to the intervention,
3 were removed from analysis (2 did
not meet eligibility, 1 no baseline data),
7 dropped out during the intervention (4 too
unwell, 1 died, 1 shingles, 1 declined) and
12 dropped out post intervention (1 died,
8 declined, 3 lost to follow-up). Of the
54 allocated to the control, 3 were removed
from analysis (2 did not meet eligibility,
1 no baseline data) and 10 dropped out
(5 died, 4 declined, 1 lost to follow-up)
Pearce et al. 2006154 NR – abstract available only 51 NR – abstract available only
Yates et al. 2007156 NR – abstract available only RCT 1: n = 30;
RCT 2: n = 57
NR – abstract available only
Yates et al. 2011155 NR – abstract available only 144 NR – abstract available only
NR, not reported.
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Having new techniques to actively respond to their breathlessness also led to feeling more ‘in control’ and,
in some cases, meant that breathing felt easier. Others felt that the sensation of breathlessness was unchanged,
but their reaction to it had changed. Knowing more about the support that exists and is available to them,
including the holistic services, also resulted in reduced feelings of isolation. Alongside this, participants
reported being more able to maintain and/or increase their daily activities and reported an increased use of
self-management strategies.
Challenges for services
Two potential challenges for services were identified (Box 3). First, participants’ accounts showed the
importance of motivation to self-manage in the success of the interventions, yet this was sometimes
difficult to achieve if the participants did not perceive benefits relatively quickly. Second, some participants
had low expectations of what these services, or their component interventions, could achieve. This
sometimes resulted in a reluctance to engage with the interventions and/or services.
BOX 1 Qualitative data on valued service characteristics
Valued service characteristics
Education and information-sharing
I, I use that as my reference [patient points to the BSS patient tool kit] all the time [interviewer: do you?].
When I’m having problems I go back and read it to see if I am doing the right thing. I find that very,
very helpful.
Man with interstitial lung disease94
Caring and expert service providers
. . . would you like a cup a tea’ [. . .] it’s just human-to-human situation. But that environment makes you:
you are in the right place, you know. There is no guessing going on [. . .]. You are gonna get the best of
their mind [. . .], and they display that to you.
P01043, man with COPD160
Involving carers
So she did give me some leaders as to what I can do to help, knowing now that he won’t die in one of
these sort of situations, so that certainly helped me, and it certainly helped me to realise that, you know,
I can probably help him to calm down. So yes, as a carer I think it was a help.
038t3c, non-malignant condition95
Psychological support
I was able to discuss my personal feelings, that you don’t talk to your family about so not to worry them.
69-year-old woman with COPD103
Simple, portable and effective tools
. . . but her telling me that and another thing as well, when I get out of breath, is to put my hand on my
tummy . . . puff puff puff . . . and do that, and you know, it’s amazing really, it sounds so pathetic when
you say something . . . It is simple, it’s not a thing you’d think of doing.
530t3pc, malignant condition91
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BOX 2 Qualitative data on perceived outcomes
Perceived outcomes
Affective distress
Increased self-efficacy: ‘. . . the intervention group were able to describe how they were increasing activity
and functional levels by using breathing techniques and exploiting the confidence these gave them.’
(Researcher comments)90
Feeling more ‘in control’: ‘. . . the blissful thing is, like I’ve said is, you can control your breathing, if you
get a bad spell you can work your way through it whereas previously when I was choking I really did not
know what to do, how serious it was. Now I realise it’s something I can, I can cope with.’
(Man with interstitial lung disease)94
Feeling less isolated: ‘The main benefit deduced from discussions with patients and answers to
questionnaires by was that they felt less isolated than they had prior to undertaking the programme.’
(Researcher comment)167
Sensory-perceptual experience
Perceived impact on what breathing feels like: ‘It helped me to learn to relax, learn to breathe in a more
controlled way.’
(54-year-old man with COPD)103
Symptom impact or burden
Improved daily activities: ‘. . . felt she wouldn’t be able to do the stairs. Went up and down with very little
increase in respiratory rate. Flung her arms around my neck and said ‘I never thought I would be able to
do that again.’
(Staff comment 11)161
Increased self-management: ‘. . . because before I would get into a panic when I was breathless, but now I
can sit down use my fan, wet my face, read my laminate (breathlessness poem) and I calm down pretty quick.’
(Woman with COPD)94
BOX 3 Qualitative data on challenges to services
Challenges to services
Motivation: ‘She gave me a fan and told me to, you know, put it on . . . and then blow out. I do try to do it,
but I get so out of breath doing it. I give up.’
(Case 013, non-malignant condition)102
Expectations: ‘Hoping that something would help me but a little bit cynical as well . . . I didn’t see how
anything could help improve it.’
(03M)105
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Chapter 4 Responder analysis results
Description of pooled data
The pooled data set included data for 259 individual patients. Most participants were male (54.3%) and
common diagnoses included COPD (49.8%), cancer (34.7%) and interstitial lung disease (10.4%). Table 9
shows the sample baseline characteristics.
TABLE 9 Responder analysis sample characteristics
Variable
Higginson et al.,94
mean (SD)/n (%)
Farquhar et al.,91
mean (SD)/n (%)
Farquhar et al.,95
mean (SD)/n (%)
Total, mean
(SD)/n (%)
Age 67.0 (9.9) 68.7 (11.5) 72.2 (10.0) 69.2 (10.6)
Sex (female) 44 (41.9) 40 (60.6) 34 (39.1) 118 (45.7)
Diagnosis
COPD 55 (52.4%) – 74 (85.1) 129 (49.8)
ILD 19 (18.1%) – 8 (9.2) 27 (10.4)
Cancer 22 (21.0%) 67 (100%) 1 (1.1) 90 (34.7)
Other 9 (8.6%) – 4 (4.6) 13 (5)
FEV1% predicted 46.1 (24.2) – 46.2 (21.4) 46.1 (22.9)
NRS
Breathlessness (average in the
last 24 hours)a
5.99 (2.07) 3.93 (1.96) 4.38 (1.86) 4.89 (2.16)
Distress due to breathlessnessa – 4.85 (2.90) 5.21 (2.74) 5.06 (2.80)
HADS
Anxietya 9.39 (2.90) 7.36 (3.82) 8.20 (4.01) 8.44 (3.64)
Depressiona 10.36 (2.93) 6.44 (2.79) 7.23 (3.55) 8.24 (3.56)
EQ-5D
VAS 53.3 (17.8) 57.8 (18.5) 54.4 (18.8) 54.8 (18.4)
Utility Index 0.39 (0.32) 0.59 (0.24) 0.50 (0.28) 0.48 (0.29)
CRQ
Dyspnoea 2.25 (0.81) 3.61 (1.07) 3.25 (0.96) 2.95 (1.09)
Fatigue 2.84 (1.38) 3.30 (1.22) 3.10 (1.08) 3.05 (14.25)
Emotional function 3.72 (1.31) 4.44 (1.06) 4.09 (1.08) 4.03 (1.20)
Mastery 3.54 (1.40) 4.64 (1.17) 4.04 (1.24) 3.99 (1.36)
Responders
Mastery 36 (51.4) 17 (34.0) 44 (59.5) 97 (50)
NRS distress – 36 (69.2) 45 (58.4) 81 (62.8)
ILD, interstitial lung disease.
a Lower scores desirable.
Reproduced with permission from Brighton et al.171 This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial
use, reproduction and distribution of the work without further permission provided the original work is attributed as specified
on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
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Predictors of response
Chronic Respiratory Disease Questionnaire mastery
Of the participants for whom the CRQ mastery response could be calculated, half (97/194) were classed as
responders. Variables significantly associated with a CRQ mastery response in the univariate analyses included
CRQ mastery (p < 0.001), CRQ dyspnoea (p = 0.008), CRQ fatigue (p = 0.009), EQ-5D Utility Index (p = 0.007),
EQ-5D VAS (p = 0.014) and NRS average breathlessness in the last 24 hours (p = 0.039) (Table 10).
Baseline CRQ mastery remained the only significant predictor of intervention response in the multivariate
regression when controlling for age, sex and original study. Participants with lower baseline CRQ mastery scores
were more likely to respond on this measure [odds ratio (OR) 0.57, 95% CI 0.43 to 0.74; p < 0.001] (Table 11).
Seventy-six per cent (n = 31) of participants with a baseline CRQ mastery score of ≤ 2 responded to the
intervention, whereas 53% (n = 49) of those scoring 3–5 and 28% (n = 17) of those with a score of ≥ 5
responded on this measure.
Numeric Rating Scale distress due to breathlessness
Of participants for whom NRS distress response could be calculated, 81 out of 129 (62.8%) were classed
as responders. The baseline NRS distress score was the only variable significantly related to distress
response in the univariate analysis (p < 0.001) (Table 12).
TABLE 10 Univariate logistic regression for mastery response (N= 189–194)
Variable n OR 95% CI p-value
Age 194 1.01 0.99 to 1.04 0.38
HADS anxietya 189 1.05 0.97 to 1.14 0.21
HADS depressiona 189 1.02 0.94 to 1.10 0.67
EQ-5D VAS 193 0.98 0.96 to 0.996 0.01b
EQ-5D Utility Index 194 0.24 0.08 to 0.68 0.01b
CRQ dyspnoea 191 0.69 0.53 to 0.91 0.01b
CRQ fatigue 193 0.72 0.57 to 0.92 0.01b
CRQ emotion 193 0.81 0.64 to 1.03 0.09
CRQ mastery 194 0.55 0.43 to 0.71 < 0.001b
NRS average breathlessness in the last 24 hoursa 193 1.15 1.01 to 1.32 0.04b
Sex (female) 193 1.56 0.88 to 2.77 0.13b
Diagnosis (reference COPD) 194
ILD 0.56 0.20 to 1.42 0.21
Cancer 0.58 0.31 to 1.10 0.10
Other 1.61 0.38 to 6.79 0.52
Original study (reference group: Farquhar et al.95) 194
Farquhar et al.91 0.35 0.17 to 0.74 0.01b
Higginson et al.94 0.72 0.37 to 1.40 0.33
FEV1% predicted 51 1.01 0.98 to 1.03 0.70
ILD, interstitial lung disease; OR, odds ratio.
a Lower scores desirable.
b Significant at p < 0.05.
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In the multivariate model, participants with a higher NRS score at baseline were more likely to respond on
this measure than those with a low score (OR 1.64, 95% CI 1.35 to 2.03; p < 0.001) (Table 13).
Eighty-nine per cent of participants (n = 41) with a ‘severe’ (≥ 7) baseline NRS distress score responded to
the intervention, whereas 59% (n = 23) of those with ‘moderate’ scores (4–6) and 39% (n = 17) of those
with ‘mild’ scores (≤ 3) responded on this measure.
TABLE 11 Predictors of response on CRQ mastery in multivariate logistic regressiona (n= 188)
Variable OR 95% CI p-value
Original study: bFarquhar et al.91 0.43 0.19 to 1.00 0.05
Original study: bHigginson et al.94 0.62 0.29 to 1.31 0.21
Age 1.02 0.99 to 1.05 0.13
Sex (female) 1.68 0.87 to 3.24 0.12
CRQ mastery 0.57 0.43 to 0.74 < 0.001c
a CRQ mastery model: χ2 (5, n = 188) = 31.309, p < 0.001; area under the curve = 0.729.
b Reference group: Farquhar et al.95
c Significant at p < 0.05.
TABLE 12 Univariate logistic regression for distress response (N= 126–129)
Variable n OR 95% CI p-value
Age 129 1.01 0.97 to 1.04 0.75
HADS anxietya 126 1.03 0.94 to 1.12 0.58
HADS depressiona 126 0.98 0.88 to 1.10 0.77
EQ-5D VAS 129 1.00 0.98 to 1.02 0.78
EQ-5D Index 129 0.79 0.20 to 3.17 0.74
CRQ dyspnoea 126 0.76 0.53 to 1.09 0.13
CRQ fatigue 127 0.93 0.67 to 1.28 0.64
CRQ emotion 127 0.90 0.65 to 1.24 0.51
CRQ mastery 127 0.77 0.58 to 1.04 0.09
NRS average breathlessness in the last 24 hoursa 129 1.16 0.96 to 1.40 0.13
NRS distressa 129 1.52 1.28 to 1.80 < 0.001b
Sex (female) 128 1.55 0.75 to 3.19 0.24
Diagnosis (reference COPD)
ILD 129 0.27 0.05 to 1.48 0.13
Cancer 129 1.54 0.72 to 3.32 0.27
Other 129 2.00 0.20 to 20.29 0.56
Original study: cFarquhar et al.91 129 1.60 0.76 to 3.36 0.22
FEV1% predicted 53 0.99 0.96 to 1.01 0.28
ILD, interstitial lung disease.
a Lower scores desirable.
b Significant at p < 0.05.
c Reference group: Farquhar et al.95
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TABLE 13 Predictors of response on NRS distress in multivariate logistic regressiona (n= 128)
Variable OR 95% CI p-value
Original study: bFarquhar et al.91 2.40 0.95 6.09 0.06
Age 1.03 0.99 1.07 0.18
Sex (female) 2.31 0.94 5.72 0.07
NRS distress 1.64 1.35 2.03 < 0.001c
a NRS distress model: χ2 (4, n = 128) = 39.258, p < 0.001; area under the curve = 0.820.
b Reference group: Farquhar et al.95
c Significant at p < 0.05.
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Chapter 5 Transparent expert consultation results
Stakeholder workshop results
Attendance
The workshop was attended by 37 stakeholders (40 registered and 117 were invited). Most attendees were
from the UK (including Bristol, Cambridge, Exeter, Glasgow, Leicester, London, Norwich, Nottingham and
York); however, two were visiting the UK from abroad (Australia and the Netherlands) and were able to attend.
Of the 37 event attendees, 33 stakeholders participated in the group work and completed response booklets
(there were three groups: one with 8 participants, one with 12 and one with 13). An additional two response
booklets were completed by patient representatives who were unable to attend the event but wanted to
provide their input. Table 14 shows the characteristics of participants who completed the response booklets.
TABLE 14 Characteristics of stakeholders who completed the workshop response booklet
Characteristic Workshop booklets (N= 35),a n (%)
Profession/role
Doctor (clinical) 16 (47)
Researcher 17 (50)
Physiotherapist 4 (10.8)
Patient/carer representative 3 (8.6)
Role in charitable organisation 2 (5.8)
Nurse 2 (5.8)
Commissioner 2 (5.8)
Occupational therapist 1 (2.9)
Psychologist 1 (2.9)
Otherb 2 (5.8)
Area of expertise
Lung disease 16 (47)
Palliative care 17 (50)
Research 13 (38.2)
Cancer 6 (17.6)
Patient/carer 3 (8.6)
General practice 1 (2.9)
Heart disease 6 (5.8)
Psychology 2 (5.8)
Geriatrics 4 (10.8)
Otherc 2 (5.8)
a Workshop and survey participants could select more than one option for both sections.
b Music and mindfulness therapist.
c Rehabilitation, breathlessness/informal carers.
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Prompt question booklet responses
Group 1: how do we define and deliver ‘holistic breathlessness services’?
Participants suggested that to define and deliver these services, different models of care needed to be
evaluated for clinical effectiveness and cost-effectiveness. These services need to be evidence based and
integrated, with collection of routine data to review access and outcomes. A key component of delivery
should be establishing and upskilling a range of clinicians in core breathlessness management skills, and
supporting these staff to integrate these skills into their routine practice. Table 15 shows a summary of
responses and example quotations.
TABLE 15 Booklet responses: how do we define and deliver holistic breathlessness services?
Question Summary of responses Example quotations
What are the core components of
a holistic breathlessness service?
Education and self-management
skills
Comprehensive, person-centred,
multidisciplinary team assessments
Support (e.g. counselling, groups)
Treatment of symptoms/reversible
causes
Education, to understand breathlessness
and provide coping strategies to enable
patients to function as best they can and to
do the things they want to do that are
important to them
1004
Comprehensive assessment exploring
patient experience of breathlessness
1005
Which staff should lead and
contribute to a holistic
breathlessness service?
Multidisciplinary including: GPs,
physiotherapists, OTs, nurses,
psychologists, respiratory/
cardiology/oncology specialists,
and palliative care teams
Anyone with an interest
Needs to be ‘joined up’ trained staff
1011
All – Drs, nurses, physios, OTs, HCAs,
[admin], psychologists
1009
Who should be referred to holistic
breathlessness services, and
when?
Anyone suffering from refractory
breathlessness
Early in diagnosis
When ‘usual treatment’ stops
working
Any condition (advanced progressive
disease) causing breathlessness which
interferes with the patient’s function or
daily life or/and is distressing them
1004
All breathlessness patients regardless
of diagnosis
1008
What is the optimal contact time,
and over what duration, for a
holistic breathlessness service?
Initial multidisciplinary team
assessment of 1–2 hours, plus
another 1–3 1-hour appointments
Long term/open access
Self re-referral
Until breathlessness improves
using taught self-management
techniques
Once you are assessed as having chronic
intractable breathlessness you should never
leave the service . . .
1010
. . . option for patient contact if required
1005
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Group 2: how and where can holistic breathlessness services be integrated into
current practice?
Participants felt that upskilling clinicians in breathlessness management skills was core to integrating
breathlessness services. This should include attention to both the physical and the psychological
components of breathlessness, should consider ways to enable self-management, and should not be
disease specific. Challenges with service integration and different approaches across different localities
were noted. Table 16 shows a summary of responses to each question and example quotations.
TABLE 15 Booklet responses: how do we define and deliver holistic breathlessness services? (continued )
Question Summary of responses Example quotations
Where should a holistic
breathlessness service be
positioned and delivered?
Community
Access to hospital services if needed
Respiratory/cardiology input
GP involvement
The community aspect is very important
because that is where the patients
experience their breathlessness and where
they manage it (at home)
1004
Where possible, merge with existing services
with models of sharing staff expertise
1003
What future research is needed
around the definition and delivery
of holistic breathlessness service?
Need to identify beneficial
components – strong evidence
needed
Cost-effectiveness
. . . we need a robust long-term (ideally
pooled [internationally]) data from cohort
to also examine the impact of these new
services
1002
. . . cost of services vs. effectiveness
1001
GP, general practitioner; HCA, health-care assistant; OT, occupational therapist.
Note
Words or terms within square brackets indicate judgements by scribes because of illegible participant handwriting.
TABLE 16 Booklet responses: how and where can holistic breathlessness services be integrated into current
practice?
Question Summary of responses Example quotations
Where should a holistic
breathlessness service be based?
Based in the community with
hospital access, if required
(e.g. home visits, GP surgeries)
Wherever appropriate
An obvious place is primary care. Most GP
surgeries have spaces that could be used for
group support – whether carer support or
education – or psychosocial/specialist nurse
facilitated patient support. Ideally these
provide the ‘missing piece’ that PR may not
be accessing
2005
Which services should contribute
to a holistic breathlessness
service?
Respiratory, cardiology,
palliative care, psychologists,
physiotherapist/OT, social work.
To a lesser extent rehabilitation
and frailty services, community
support groups
Physical, psychological, social/
relational and spiritual aspects
need to be considered
. . . to be truly holistic, there needs to
be equal weight given to the physical,
psychological, social/relational and spiritual
aspects of breathless person’s experience . . .
2005
continued
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TABLE 16 Booklet responses: how and where can holistic breathlessness services be integrated into current
practice? (continued )
Question Summary of responses Example quotations
How should people be referred to
a holistic breathlessness service?
Multiple referrals routes rather
than one specific place or
specialty. Could include GPs,
community and rehabilitation
services and respiratory and
cardiology specialists
Self-referral is both advocated by
some and explicitly stated as
inappropriate by others
Multiple points of entry so no one is
missed . . .
2006
A holistic service needs to have multiple
avenues for referral to allow speedy referral
and treatment
2007
How do we best raise awareness
of a holistic breathlessness
service?
Educating and engaging clinicians
(across multiple specialties),
commissioners and the public,
particularly within relevant local
care pathways and existing
charity-led initiatives (e.g. patient/
carer groups; GP surgeries; PR
classes, BLF patient passports,
CPD events)
Disseminate evidence regarding
outcomes and value for money
Inclusion in national guidance
Earlier focus on supportive care
Blogs and social media
Staff need to be educated about what the
service will offer and what benefit it has
for patients
2007
I recently took part in a PPI exercise . . .
what struck me was the public’s huge thirst
for information about breathlessness and
how to self-manage
2005
What could help facilitate
integration of holistic
breathlessness services into
current practice?
Evidence of acceptability and
cost-effectiveness
Integration of key elements into
existing practice (e.g. respiratory
and cardiac pathways) and
upskilling existing staff.
Multidisciplinary working
Evidence that it is valued by patients
and carers
2001
Identify what elements are already provided
in current services . . . identify gaps and
add in
2003
What future research is needed
around integration of holistic
breathlessness services into
practice?
What is already being delivered in
practice, and consider integration
into existing services rather than
standalone
Identify necessary service
elements, influence of patient
factors on outcomes, and patient/
carer preferences on service
design. Considering inclusion of
exercise, supportive technology,
carer support and longer-term
follow-up
Timing of referral (e.g. following
hospital admission)
How best to support carers
2001
Specify necessary service elements
2008
BLF, British Lung Foundation; CPD, continuing professional development; GP, general practitioner; HCA, health-care
assistant; OT, occupational therapist; PR, pulmonary rehabilitation.
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Group 3: how should the success of holistic breathlessness services be measured/
monitored?
Discussions centred around ensuring that outcomes were patient led, clearly mapped to service aims and
psychometrically robust. Inclusion (and development) of carer-reported outcomes was also discussed.
Participants felt strongly that any approach to measurement should be based on existing successful
methods, should be consistent and should be integrated with existing practice. Table 17 shows a summary
of responses to each question and example quotations.
TABLE 17 Booklet responses: how should the success of holistic breathlessness services be measured/monitored?
Question Summary of responses Example quotations
What is the ideal set of outcomes
to measure for patients?
Measures should focus on what is
important to patients. This may
include breathlessness (including
mastery of, and distress due to
breathlessness), health-related
QoL, health status, physical
activity, capacity and/or function,
psychological and social well-
being, patient-centred goals,
health-care and medication use,
comorbidities (e.g. frailty),
acceptability and experiences
Measures should be consistent
across services and
psychometrically validated
Actually ask the individual what they would
like to achieve/happen?
3011
I think it is key that the outcome measures
are there that are identified as important to
the patient
3001
What is the ideal set of outcomes
to measure for carers?
Measures should focus on what
is important to carers. This may
include health-related QoL, health-
care utilisation, psychological and
social well-being, carer burden
and/or preparedness to care,
quality of their relationship with the
patient, ability to live with patients’
breathlessness, support needs (e.g.
information, financial), acceptability
and experiences, and proxy patient
outcomes (e.g. breathlessness)
Impact and burden of caring in including
physical, psychological and financial. What
aspects of the breathlessness intervention
has helped them most
3001
Again, outcomes need to reflect the things
that are important to the carer
3005
What is the ideal set of service-
level variables to monitor?
Measures should be consistent
(between and within services)
and realistic. This may include
interventions delivered, staffing
required, referral source, service
usage (e.g. uptake, dropouts),
service user characteristics
(including monitoring equality of
access), provider and service user
experiences, patient outcomes
(including health-care utilisation),
and cost-effectiveness
Completion of service use – approach,
take up, dropout, completion
3007
Staff members involved, associated costs,
staff members’ views on the services
3006
continued
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Individual suggestions
Across the three parallel groups, stakeholders made 187 individual suggestions in their participant booklets.
Most of the participants’ suggestions had implications for research (n = 101), followed by implications
for clinical care (n = 76) and then policy (n = 41; multiple categories could be selected). Synthesis of these
187 suggestions resulted in 34 statements for inclusion in the online consensus survey.
Event summary
Throughout the stakeholder workshop, the need for improved collaboration, integrated working and
standardisation were strong themes. Stakeholders acknowledged the successful components of existing
practices, across multiple specialties and disciplines, which should be developed but not duplicated.
Figure 5 shows the graphic recording summarising discussions throughout the workshop.
TABLE 17 Booklet responses: how should the success of holistic breathlessness services be measured/monitored?
(continued )
Question Summary of responses Example quotations
What data will need to be
collected to inform
commissioning?
Population needs and access,
including equality and diversity
implications
Patient and carer outcomes and
experiences, including health-care
utilisation
Cost-effectiveness
Value – either enhanced QoL for same costs
or improved outcomes for increased cost
3009
What could help facilitate
measurement and monitoring of
success?
PPI (e.g. in selection of measures)
Use of or integration into routine
data collection (e.g. align with
existing audits
Dedicated training/support/
funding for measurement and
monitoring
Include measurement as part of
service contract (e.g. payment by
results)
Measures should be used
consistently across services,
psychometrically validated, and
timed in order to best capture
changes
Identify a core set of variables and embed
the data collection into routine practice
3006
. . . using the same measurement tools as
similar services: consistency, easier to
pool data
3004
What future research is needed
around measurement and
monitoring the success of holistic
breathlessness services?
Establishing core service
components
Identifying predictors of uptake
and optimal outcomes
Identifying outcomes most
important to patients and carers
Understanding how best to
embed routine data collection in
clinical practice
Development of carer-reported
outcome measures
Ascertaining what outcomes are most
important to the patient and carer, and
translating those wishes/wants/desires
into outcomes which tick the boxes for
commissioners
3011
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FIGURE 5 Graphic recording of stakeholder workshop discussions. Reproduced with permission from Joel Cooper,
April 2019.
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Consensus survey results
Respondents
Those invited to the workshop, plus an additional 43 stakeholders, were invited to take part in the online
consensus survey. Of the 160 invited, 72 participated (an additional two participated after receiving an
invite forwarded from an originally invited participant), representing a 46% response rate. Seventy-eight
invitees did not respond, six were away until after the survey close date, three e-mail addresses were
invalid and one person declined. Twenty-six of those who responded to the consensus survey had completed
a workshop response booklet. Table 18 shows the characteristics of participants who completed the online
consensus survey.
TABLE 18 Characteristics of participants who completed the consensus survey
Characteristic Online survey (N= 74),a n (%)
Profession/role
Doctor (clinical) 30 (40.5)
Researcher 29 (39.2)
Physiotherapist 11 (14.8)
Patient/carer representative 9 (12.2)
Role in charitable organisation 9 (12.2)
Nurse 7 (9.5)
Commissioner 4 (5.4)
Occupational therapist 0 (0)
Psychologist 2 (2.7)
Otherb 1 (1.4)
Area of expertise
Lung disease 43 (58.1)
Palliative care 29 (39.2)
Research 28 (37.8)
Cancer 12 (16.2)
I am a patient/carer 10 (13.5)
General practice 7 (9.5)
Heart disease 5 (6.8)
Psychology 5 (6.8)
Geriatrics 4 (5.4)
Otherc 4 (5.4)
a Workshop and survey participants could select more than one option for both sections.
b Music and mindfulness therapist.
c Rehabilitation, cognitive–behavioural therapist, breathlessness/informal carers and dermatology.
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Survey responses
Of the 34 final statements from participants included in the online survey, 10 related to clinical practice,
eight to policy, and 16 to research. Figure 6 shows boxplots of online consensus survey scores. The
majority (n = 20) of participants received strong agreement but low consensus, seven participants received
strong agreement and high consensus, six participants received moderate agreement and low consensus,
and one participant received moderate agreement and high consensus. No statements were disagreed
with. Participants’ priorities for clinical practice were more often met with strong agreement and high
consensus, with lowest agreement and consensus being around participants’ priorities for research.
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FIGURE 6 Boxplots of online consensus survey scores. (a) Clinical priorities; (b) policy priorities; and (c) research
priorities. Reproduced with permission from Brighton et al.172 This article is distributed under the terms of the
Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/)
which permits non-commercial use, reproduction and distribution of the work without further permission provided
the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/
open-access-at-sage). (continued )
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Stakeholders’ priorities for clinical practice
The most strongly supported statements from stakeholders relating to clinical practice were those calling
for flexible and accessible person-centred care (C1) and drawing on multiple expertise (C2), with the widest
possible coverage geographically and demographically (C3) (Table 19). They also included acknowledgement
of the role of informal carers (C7), valuing responding to (and being able to respond to) breathlessness as a
symptom in its own right (C9) and sharing breathlessness management skills between other professionals
and with informal carers (C10). Free-text consensus survey comments also highlighted the need for
multidisciplinary, person-centred, holistic care, which particularly acknowledged psychological concerns:
Health-care professionals should have knowledge of physical and psychological ways to manage
breathlessness and should assess these areas. Generally, the psychological impact of breathlessness
is ignored.
Participant 5026
Important to take a holistic view of breathlessness and support the wider psychological, social and
practical implications.
Participant 5002
TABLE 19 Participants’ priorities for clinical practice and online survey responses
Participants’ priorities for clinical practice when working with people with chronic
breathlessness in advanced disease (statement ID) Median (IQR)a
Strong agreement, high consensus
Ensure breathlessness services are person-centred and flexible in terms of delivery (e.g. appointment
location, time, and duration) (C1)
9 (8–9)
Ensure breathlessness services are cross-cutting, drawing on relevant expertise from multiple disciplines,
professions and providers (C2)
9 (8–9)
Work towards ensuring that breathlessness services have the widest possible geographical coverage and
access (e.g. travelling communities, people who are homeless, people living in care/nursing homes) (C3)
9 (8–9)
Acknowledge family and/or informal carers within breathlessness services and, when appropriate, actively
encourage their participation in education and in management of the patient’s breathlessness (C7)
9 (8–9)
Value symptom management in its own right, and be able to deliver, or refer patients for, breathlessness
interventions (C9)
9 (8–9)
Share breathlessness management skills with other health and social care professionals, and informal
carers (C10)
9 (8–9)
Strong agreement, low consensus
Define clear referral criteria for breathlessness services (e.g. limiting breathlessness that persists despite
optional management of underlying disease) and share these with potential referrers (C4)
8 (7–9)
Use multiple strategies to raise awareness of breathlessness services among potential referrers and the
public (e.g. by engaging with professional bodies, charities or patient groups) (C6)
8 (7–9)
Be alert to, and respond to, under-recognised related issues (e.g. sleep, intimacy) (C8) 8 (7–9)
Moderate agreement, low consensus
Consider providing the option for patients to self-refer to breathlessness services (C5) 7 (6–9)
a Scores ranged from 1 to 9.
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Despite strong agreement, there was low consensus around defining referral criteria (C4), using multiple
strategies to raise awareness of breathlessness (C6) and responding to under-recognised related issues (C8).
One respondent noted that referral structures should not be too rigid, as this may be a barrier when
presentation to the service is atypical:
I have stated strongly agree for the need for clear referral criteria. However, referral criteria should be
inclusive and aim to capture all those limited by breathlessness. Rigid referral criteria risk excluding
people who don’t present typically.
Participant 2003
The most contentious statement was around the option for patients to self-refer to services (C5);
comments revealed concerns around self-referral and ensuring joined up health-care, ensuring medical
record access and ensuring that medications are maximised and reversible conditions ruled out. Additional
comments also noted that the role of the wider community should be considered.
Stakeholders’ priorities for policy
The most strongly supported of participants’ statements relating to policy was recognition of informal
carers in terms of their role, importance and support needs (P7) (Table 20). The remaining statements
received high overall agreement but low consensus. The comments highlighted the contention over the
utility of mapping (P1, P3) and national audit (P4, P5), questioning their benefit to day-to-day practice.
Others felt that this was a necessary first step:
Needs assessment and mapping would logically precede further service development (avoid
duplication) and quality standards/audit should come as evidence expands.
Participant 5047
TABLE 20 Participants’ priorities for policy and online survey responses
Participants’ priorities for policy relating to people with chronic breathlessness in advanced
disease (statement ID) Median (IQR)a
Strong agreement, high consensus
Recognise informal carers in terms of their role, importance, and support needs (P7) 9 (8–9)
Strong agreement, low consensus
Complete a needs assessment around breathlessness, map it to current service provision and consider
areas for service improvement (P1)
8 (7–9)
Prioritise supporting development of breathlessness-triggered services, which span all stages of multiple
diseases and conditions (P2)
8 (7–9)
Map how breathlessness services could sit within existing care provision and plans, to avoid duplication (P3) 8 (7–9)
Agree, publish, and review breathlessness service quality standards as new evidence accumulates (P4) 8 (7–9)
Establish an audit programme for breathlessness services to track impact of services nationally or
internationally (P5)
8 (7–9)
Increase public awareness and/or education around breathlessness (e.g. as a sign of disease vs. normal
exertional symptom) (P6)
8 (7–9)
Provide all health and social care staff with education around breathlessness and its management, ideally
starting during vocational and/or undergraduate training and continuing throughout professional lives (P8)
8 (7–9)
a Scores ranged from 1 to 9.
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Multiple comments stressed the importance of the priority area of education, to increase awareness
among the general public as well as health and social care professionals (P6, P8), particularly to support
existing services. It was also suggested that breathlessness-triggered services (P2) should be developed
through adapting existing services rather than introducing something new, and that this might be achieved
by educating and upskilling care staff:
Re. policy – there are so many symptoms and diseases that compete for limited resources, so this is
challenging. But educating all health professionals from undergrad onwards is probably the most
important issue to change practice long term.
Participant 1002
One respondent commented that the policy statements were health-care focused, despite people with
breathlessness spending most of their time outside the health services. It was suggested that work might
be undertaken to understand the role of psychological approaches (e.g. cognitive–behavioural therapies),
social care and communities in supporting patients with breathlessness and their carers.
Stakeholders’ priorities for research
None of the participants’ statements relating to research received high agreement and high consensus
(Table 21). The need for economic modelling of breathlessness services (R9) was the only statement
receiving high consensus (and moderate agreement). This gap in evidence was reflected in the limited
economic data available from studies and services included in the systematic review.
The remaining statements from participants received low consensus, with strong (R1, R3–7, R10, R14–16)
or moderate (R2, R8, R11–13) agreement. Free-text responses to the research statements suggested that
the low consensus may result, in part, from inadequate definitions of the population of interest (e.g. for
people having unplanned admissions due to breathlessness: R7) or insufficient justification for the area of
research (e.g. effectiveness for care/nursing home residents: R8). Stakeholders also indicated that they had
assigned lower agreement when they believed that the existing knowledge base was already well understood
(e.g. the impact of breathlessness: R1):
I rated those low of which I believe there is already clear understanding, not because they are
unimportant. Understanding impact for example – this is well documented – the focus now needs to
be on solutions.
Participant 5009
It was emphasised that this evidence should be built on to develop effective solutions to the issues already
identified. Proposed avenues for future research included identifying the best way to support informal
carers; the role of charity, voluntary and community groups; involving patients in service development;
and the role of psychology and emotion:
More research into the role of anxiety/emotions/health behaviours and beliefs and breathless, and
psychosocial interventions to positively affect these factors.
Participant 2005
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TABLE 21 Participants’ priorities for research and online survey responses
Participants’ priorities for policy relating to people with chronic breathlessness in advanced
disease (statement ID) Median (IQR)a
Strong agreement, low consensus
Explore optimal delivery methods of service provider education for breathlessness assessment and
management (R16)
9 (7–9)
Understand the impact of breathlessness and associated factors (e.g. fatigue or isolation) on health and
social care service use and costs (R1)
8 (7–9)
Determine medium- to long-term effects of breathlessness services using follow-up assessments beyond
completion of the intervention (R4)
8 (7–9)
Examine and understand models of integrated working between breathlessness services and other
providers (e.g. palliative, respiratory, primary, social care) (R5)
8 (7–9)
Assess the clinical effectiveness and cost-effectiveness of breathlessness services for people unable to
engage in cardiac/respiratory rehabilitation services (R6)
8 (7–9)
Assess the clinical effectiveness and cost-effectiveness of breathlessness services for people who have
had their first unplanned hospital admission related to breathlessness (R7)
8 (7–9)
Assess the clinical effectiveness and cost-effectiveness of the following components within breathlessness
services: carer-focused interventions (R10)
8 (7–9)
Assess need for service provider education around breathlessness (R15) 8 (7–9)
Establish a core set of outcome measures for clinical practice and research, incorporating validated
patient and carer measures (R3)
8 (7–9)
Complete economic modelling (including cost-effectiveness studies) of breathlessness services, which
should include health and societal perspectives (R14)
8 (6.25–9)
Moderate agreement, high consensus
Assess the clinical effectiveness and cost-effectiveness of the following components within breathlessness
services: structured exercise training (R9)
7 (7–8.75)
Moderate agreement, low consensus
Assess the clinical effectiveness and cost-effectiveness of breathlessness services for care/nursing home
residents (R8)
7 (6–9)
Convene a representative group of funders/commissioners to establish the type of outcomes they would
need to see for breathlessness services (R2)
7 (6–8)
Assess the clinical effectiveness and cost-effectiveness of the following components within breathlessness
services: telehealth (e.g. virtual multidisciplinary team meetings, video resources for patients/carers) (R11)
7 (6–8)
Assess the clinical effectiveness and cost-effectiveness of the value of the following variations of
breathlessness services: as an adjunct to existing services (e.g. pulmonary rehabilitation) (R12)
7 (6–8)
Assess the clinical effectiveness and cost-effectiveness of the value of the following variations of
breathlessness services: group vs. individual delivery (R13)
7 (6–8)
a Scores ranged from 1 to 9.
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Chapter 6 Discussion and conclusion
Key findings
This project aimed provide a comprehensive and objective summary of available evidence for the clinical
effectiveness and cost-effectiveness of holistic services for people with advanced malignant and non-malignant
disease and chronic or refractory breathlessness. The systematic review found evidence of a positive
effect on the affective components of breathlessness, and on psychological health outcomes, including
depression. There was limited evidence that services led to a measurable change in overall health status or
QoL, and mixed evidence regarding an effect on physical function. Evidence for cost-effectiveness was
limited to four studies and was inconclusive. Services were heterogeneous in their content and delivery,
but most were short term (4–6 weeks) and involved a limited number of contacts with health professionals
(four to six face-to-face or telephone contacts). Patients and their informal carers valued services, particularly
highlighting the provision of dignified, person-centred care from expert staff; education and information-
sharing; and useful self-management interventions that were simple and portable, such as the handheld
fan. The responder analysis revealed that baseline mastery and distress due to breathlessness were strong
predictors of response to holistic breathlessness services. The other patient characteristics that we considered,
including diagnosis, lung function, breathlessness severity, and QoL, were not associated with treatment
outcome.
Considering these findings in the context of current service provision, the TEC elicited evidence-based
priorities from stakeholders in this field in relation to research, clinical practice and policy around the
provision, delivery and development of holistic services for chronic or refractory breathlessness. Participants
showed strongest agreement and consensus on statements centred around improving access to symptom-
focused, person-centred, multiprofessional care, as well as on statements regarding carers accessing and
sharing breathlessness management knowledge and skills. Stakeholders who participated also called for
clinical practice and policy to acknowledge and value the role of informal carers in supporting people with
advanced disease and chronic breathlessness.
Strengths and limitations
Systematic review
For the systematic review, registration of the protocol and the systematic and comprehensive search across
multiple databases (inclusive of grey literature), with no exclusions by publication year or language,
ensured that there was a high level of transparency and representativeness. The review eligibility and
quality assessments were conducted independently by two researchers. Furthermore, multiple stakeholders,
including researchers, clinicians and patient/carer representatives, contributed to both the analysis and the
interpretation of the review data. The integration of qualitative and quantitative studies was another
strength of this work and allowed for a comprehensive evaluation of service experiences and outcomes.
Recipients of services reported health benefits in line with those found with established tools, again
highlighting an effect on affective and psychological domains of health.
The review also had some limitations. The meta-analyses combined data from services with varying
structure, delivery and recipients, and there was evidence of statistical heterogeneity. We completed
sensitivity analyses in response to this, but the overall data set was moderate in size and these sensitivity
analyses inevitably compromised the precision of the effect estimates. Effect estimates may also have been
inflated by lack of blinding of study personnel, and low expectations from participants in studies for which
a fast-track design was not employed. Moreover, we did not assess for statistical evidence of publication
bias given the low number of studies, and there was some evidence of selective reporting where study
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authors did not provide data for statistically non-significant findings. Our estimates therefore do not
include these data. In addition, challenges with inconsistent use of and/or unclear reporting of outcome
measures sometimes precluded meta-analysis (e.g. for breathlessness intensity). Evidence around
cost-effectiveness was also limited by a lack of studies with an economic component.
Qualitative data were predominantly drawn from two UK services91,94,95 and patients who had fully
engaged with the services. Less is understood about the experiences of the carers, the patients using these
services internationally and those who dropped out and who perhaps might report less benefit. Finally,
although limiting our review to studies with people with advanced disease was reflective of the current
evidence base, it is important to acknowledge that limiting service access based on disease severity may
limit reach and not serve those with distressing breathlessness during early stages of disease. For this
reason, and in the light of our findings, we advocate access to these services based on the presence of
distressing chronic or refractory breathlessness, rather than disease severity.
When interpreting the data, we note that some of the study group were co-authors on included studies.
These individuals were not involved in any data extraction or quality assessment of these studies, providing
a level of objectivity and impartiality. However, we acknowledge that influences of motivated reasoning
(e.g. confirmation biases) have the potential to influence all stages of research, from deciding research
questions to presentation of findings.173 As such, team discussions encompassing those who were
co-authors (4 out of the 12 report authors) and were not co-authors on previous studies of breathlessness
services were important in balancing existing expertise and new insights, in addition to continually
exposing our findings to feedback from diverse audiences (see Dissemination strategy).
Responder analysis
A strength of this work was that individual patient data were pooled from three high-quality RCTs. The
combined data set enabled a more powerful analysis to be undertaken than would have been possible via
study-level meta-analysis. However, it did mean that the analysis was limited to variables common across
the three data sets. For this reason, we were unable to test some potentially important patient factors (e.g.
multimorbidity, functional status) and intervention characteristics (e.g. setting, duration, professional input),
which could have been important moderators of effect. There were fewer cases available for the secondary
analysis of NRS distress due to breathlessness, as this was included in only two out of the three data sets,
reducing statistical power. Finally, it is unclear to what extent the primary finding reflects regression to the
mean;174 however, the magnitude of the effect observed following the breathlessness services suggests
that this is not the only contributing factor. The finding that response was not influenced by other patient
characteristics may relate to the baseline scores of the sample. For example, baseline scores for anxiety and
depression were mild across the included studies175 and, therefore, the analysis may not have tested for
influences of higher levels of psychological distress. Conversely, this finding could relate to the tailored
nature of the services, which should consider each patient based on their physical, psychological, social
and spiritual profile.
Transparent stakeholder consultation
The diversity of stakeholders who contributed to the workshop and consensus survey was a strength of the
TEC process; participants included service providers and commissioners, voluntary sector organisations,
patient and carer representatives, as well as health and social care practitioners from a range of specialties
and professional groups. Although this diversity of knowledge of existing research may have led to lower
consensus on participants’ statements relating to research, it also led to generation of a wide variety of
suggestions for areas in need of further evidence. The priorities elicited from participants are also closely
linked to emerging evidence as a result of the workshop structure, where this information was presented
at the start for reflection and discussion. For example, participants’ suggestions around understanding the
optimal models, economic modelling and medium- to long-term effects of breathlessness services, relate
directly to findings from our systematic review, while recognition and inclusion of informal carers drew
from evidence presented around their role and its impact.
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It is also important to note that the suggestions made by our participants may be most applicable to health
and social care in UK settings, as most people in the stakeholder consultation process were based in UK
universities and NHS secondary care settings. There was also a higher number of participants with roles as
a researcher or doctor, but these were also the participants for whom having more than one role was most
common (e.g. 69% of researchers were also health-care professionals; 47% of doctors had additional roles
in research, charities and/or commissioning). A smaller number of service user representatives attended
the workshop than we had anticipated. This suggests that this engagement method may be less suited to
people living with chronic breathlessness and/or with caring responsibilities and may have biased the types
of priorities elicited from participants. However, more than 10 out of 74 (14%) respondents to the survey
identified as a patient/carer. In addition, patient/carer representatives were members of the PAG and
helped with the synthesis of the suggestions generated from the workshop participants in this role.
This included working closely together to ensure that the participants’ statements were clear and
understandable for people with a range of professional and personal expertise.
Having a clear and structured workshop process ensured that there was efficient collection of the
attendees’ views. We mitigated the risk of bias inherent in face-to-face consultation techniques, whereby
some participants may contribute to discussions more than others, by providing the opportunity to submit
individual written suggestions in the response booklets. These individual responses were the primary focus
in generating content for the consensus survey. A full Delphi process176 or having additional consultation
rounds may have provided more opportunity to refine participants’ statements, but the TEC technique
utilised the multiple forms of data collected at the workshop (including the scribe notes, graphic recording,
response booklets and audio-recordings, which enabled the rapid synthesis and revision of participants’
statements). Although this was substantially undertaken by two researchers (MM and LJB), the full list of
original suggestions had been shared with the PAG for transparency. Crucially, individual suggestions from
participants were removed or modified only in line with the reasons outlined above (e.g. duplicates, low
priority) and not on the basis of controversy or creativity. This method resulted in generally high levels of
agreement and consensus, particularly around participants’ priorities for clinical practice. The consensus
survey response rate was limited, although a high proportion of those completing the workshop booklets
participated (74%) and the overall response rate was similar to studies that have previously utilised this
method.146–148 Importantly, all key stakeholder groups were represented.
Implications
For clinical practice
To our knowledge, this evidence synthesis offers the first systematic review in this field. The bias of clinical
effect towards improved psychological health is consistent with the primary focus of holistic services to
support people with advanced disease to live with breathlessness rather than to take this symptom away.
The wider effect on psychological health may have been achieved through management of breathlessness,
but also through addressing concurrent symptoms and the receipt of expert holistic care that put the person
before their disease. The effect sizes from our meta-analyses (point estimates: distress –0.57, mastery 0.25,
anxiety –0.45, depression –0.55) are larger than those achieved with psychological therapies and self-
management programmes in similar populations, and more comparable to pulmonary rehabilitation.86,87
For NRS distress and HADS anxiety and depression, the MDs also represent a minimum clinically important
difference (> 1 and > 1.5, respectively).143,177 Although few measurable effects were identified for physical
function, we acknowledge the qualitative data from patients and carers that captured feelings of expanding
horizons, for example being able to independently complete activities of daily living. The diverse nature of
improvements in physical function may be more readily captured using individualised measures, such as
goal attainment scaling.178
The interface between holistic services for breathlessness and pulmonary rehabilitation is an important
consideration for people with chronic respiratory disease. Based on current evidence, we do not view
holistic breathlessness services as a replacement for pulmonary rehabilitation, which is a highly effective
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and underutilised intervention.81 However, these services may have a role for people who remain highly
symptomatic despite completing pulmonary rehabilitation, or as a bridge for people who decline it,
including those recently hospitalised with an acute exacerbation of disease. Holistic breathlessness services
may also provide an additional opportunity for health gains in those unable to complete programmes with
a major exercise component (e.g. in cases for which breathlessness limits exercise to an intensity associated
with a training response).28,84,179 With high levels of health service use in breathless patients and limited
resource, evidence-based factors to prioritise access based on likelihood of benefit may be useful. When
services are already in place or being established, our responder analysis suggests that there is merit in
focusing efforts on patients with poor psychological health relating to their breathlessness.
Stakeholders’ priorities for clinical practice elicited through our TEC with strongest consensus called for
flexible and accessible person-centred care, drawing on multiple expertise, and with the widest possible
coverage. Stakeholders advocated for acknowledgement of the role of informal carers, valuing and being
able to respond to breathlessness as a symptom in its own right, and sharing breathlessness management
skills between other professionals and with informal carers. Free-text survey comments from participants
underscored the need for person-centred, holistic care that acknowledged both psychological and
emotional concerns. This fits with findings from the systematic review in terms of therapeutic components
most valued by patients (e.g. tailored education, psychological support) and clinical benefit relating to
anxiety and depression. The promotion of joint working around breathlessness was also suggested in a
previous consultation focused on combined rehabilitation services for people living with COPD and heart
failure.180 This and other elements of stakeholders’ statements relating to clinical practice are in line with
a palliative care approach of person-centred care, multidisciplinary input and inclusion of informal carers
in the unit of care.54 Working to build links with, or learn from, palliative care may be an efficient way to
facilitate working in line with their priorities.
For policy
Recent international guidelines advocate for early integration of palliative care in people experiencing
chronic disease.96,97 Chronic or refractory breathlessness may serve as an appropriate referral indicator,
especially in non-cancer conditions for which the unpredictable course of disease and difficulty predicting
survival are barriers to timely palliative care referral and receipt.54 Indeed, a symptom-triggered approach
should reach more people than approaches based on prognostication.
Stakeholders’ priorities relating to policy elicited through our TEC particularly supported the recognition
of informal carers in terms of their role, importance and support needs. When appropriate, this extended
to supporting and encouraging their participation in health care. This is supported by recent evidence
demonstrating the substantial contribution of informal carers to people with advanced disease and chronic
breathlessness,35 including that their contribution saves approximately two-thirds of what would otherwise
be formal care costs,51 and the impact that this has on their own health and well-being.51,181
Our participants also stressed the importance of education, both to increase awareness among the general
public and health and social care professionals, and to upskill professionals within existing services.
Multiple stakeholders suggested that breathlessness services should be developed by adapting existing
services rather than introducing something new. They noted that educating professionals in social care and
communities about supporting people with breathlessness should also have value because, despite the
high utilisation, people with breathlessness spend most of their time outside health services.
For research
The need for economic modelling of breathlessness services was the only research recommendation that
received high consensus in our stakeholder consultation. This gap in evidence was reflected in the limited
economic data available from studies included in the systematic review. The heterogeneity of services with
respect to staffing, structure and content highlights a concurrent need to determine the most effective
service delivery models. Although the patient and carer experience data highlight valued components
(e.g. simple, portable interventions; involvement of carers), additional work is needed to understand which
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components of holistic services are most effective and how these might be integrated into, or alongside,
the existing models of care. Consistency in the use of outcome measures in future studies would permit
more detailed evaluations of comparative clinical effectiveness and cost-effectiveness. Considering our
findings around the impact of these services on NRS distress and CRQ mastery, but the shorter administration
format of the former, consistently using NRS distress due to breathlessness to measure service outcomes
could be a good starting point. Alongside this, it is crucial to acknowledge that service users should value
services and be willing to access them. Understanding what makes services attractive and acceptable to
service users could help better serve patients and provide evidence to inform more efficient resource
allocation. Discrete choice experiments could be used to identify which ‘attributes’ would be prioritised
and preferred by patients and carers.
The remaining research recommendations generated by participants received strong or moderate
agreement, but low consensus. Although this, in part, may relate to inadequate definitions or justifications
for the populations and/or settings, and differing knowledge bases of contributing stakeholders around
existing evidence, it may also reflect the diversity of issues that are in need of better evidence and the
differing opinions over which issues to prioritise. Overall, participants emphasised that research should
focus on developing effective solutions rather than revisiting the problem. Additional proposed topics for
research included the role of psychosocial factors in breathlessness management, enhancing community
support and testing the optimal ways to support informal carers of patients with breathlessness.
Dissemination strategy
Summary of outputs and dissemination methods
Through the systematic review, we have disseminated evidence on symptom-triggered services as a means
to access timely palliative care, especially in non-cancer conditions, and have provided evidence on the
effectiveness of holistic breathlessness services. The responder analysis allowed for shared knowledge on
patient characteristics that moderated treatment response from services. Furthermore, our participants
were able to share consensus- and evidence-based priorities relating to clinical practice, policy and
research.
We have shared findings via open-access publications in scientific journals.92,171,172 Plain English summaries
have been completed for each study component.182,183 This project has been presented at several meetings
to varied audiences (see List 1: presentations) and additional abstracts have been submitted [e.g. to the
ERS International Congress (https://erscongress.org/)]. Throughout this project we have engaged with PPI
representatives to provide feedback and inform the project from an external perspective. Furthermore, the
Cicely Saunders Institute ‘Open House’ and ‘Conversation Starter’ events allowed for information-sharing
with members of the public. To extend our reach further, information on our stakeholder event has been
published in online news pieces in various local and international platforms (see List 2: online news
articles). To enable engagement with a wider audience, we will share our publications, lay summaries and
the full report via several social media platforms, including an online journal club on Twitter (Twitter, Inc.,
San Francisco, CA, USA; www.twitter.com).
Our stakeholder workshop allowed for education of professional bodies and lead service managers
through presentation of relevant findings. We have shared the findings of this project directly with public
bodies and policy-makers through submission to the Taskforce for Lung Health call for evidence.184 We
may have further opportunities to present findings at the Knowledge Exchange Seminar held in the Cicely
Saunders Institute to educate colleagues, and at PPI workshop events to provide information to patient
and public representatives (both events will have a rehabilitation theme).
List 1: presentations
We gave four internal presentations, in addition to the presentation given at the stakeholder consultation
workshop. We also gave presentations at a breathlessness research interest group, the Collaboration for
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Leadership in Applied Health Research and Care (CLAHRC) South London award ceremony and the ERS
International Congress. In addition to these presentations, we presented this research to second-year
nursing students as a part of their undergraduate programme.
List 2: online news articles
l CLAHRC South London news.185
l CLAHRC North West London blog.186
Reflections on patient and public involvement
We believe that this project benefited greatly from PPI, with multiple positive impacts in keeping with our aims.
Ensuring acceptable and appropriate research processes
For the stakeholder consultation, involvement of our PPI members in reviewing the workshop groupwork
processes and refining the final list of statements from stakeholders ensured that these materials were clear
and readable by participants from all backgrounds. Their help with piloting and redesigning the online
survey to be more engaging and user-friendly was also important; for example, adding a background image
and adding an option to be contacted by the researcher if patient/carer representatives wanted assistance
completing the survey. This seemed to make these processes more acceptable to participants, including
patient/carer representatives (who formed > 10% of our online survey respondents).
Including patient/carer voices throughout the consultation with stakeholders
The PPI members have been an important part of including patient/carer voices throughout our
consultation, not only by improving the acceptability of our research methods, but also by suggesting
additional patient/carer stakeholders to invite, and, through their own participation, by completing the
workshop booklets and online consultation survey.
Ensuring interpretation of findings were grounded in patient/carer experiences
Having PPI members included across all project meetings ensured that there were opportunities to relate
emerging findings to their real-life experiences, whether this was by highlighting inconsistencies in clinical
practice or highlighting important issues related to breathlessness (e.g. relationships, including intimacy).
Including a PPI member in the thematic analysis of the systematic review data ensured that the findings
were not limited to researcher interpretations. This included raising the importance of reassurance for
patients with breathlessness in how they are already self-managing, the need for psychological support
that goes beyond just breathlessness, and the complexities of who is a ‘patient’ and who is a ‘carer’ when
both may have substantial support needs.
Improving clarity and reach of dissemination
Our PPI group’s help with dissemination so far, commenting on the systematic review paper92 and co-authoring
the stakeholder paper,172 has ensured increased reporting clarity. In our project meetings, they have also
suggested additional ideas for disseminations to increase reach (e.g. through the NIHR INVOLVE network),
and have agreed to help write plain English summaries to share alongside publications as they are accepted.
Patient and public involvement member reflections
Box 4 provides direct quotations taken from our PPI members reflecting on their work on the project and
with the research team. Our PPI members said that they appreciated the opportunity to get involved in a
variety of tasks and being given specific training (including one-to-one sessions) when required. They
acknowledged that some of the more technical research methods could be difficult to understand at times
but appreciated that the research team took time to explain and respond to questions about this during
and outside meetings. Overall, they commented that they felt valued as part of the project team, leading
to more rewarding and satisfying involvement.
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Conclusions
In people with advanced disease, holistic services for chronic or refractory breathlessness led to
improvements in psychological aspects of breathlessness and health. Services are heterogeneous in their
content and delivery, but are highly valued by patients and families, who appreciate the tailored education
around breathlessness; the provision of simple, portable self-management interventions; and the expert
staff who provide person-centred, dignified care. Clinical response to these services is more likely in
patients with low levels of mastery and high levels of distress related to their breathlessness at baseline,
but is not influenced by breathlessness intensity, diagnosis, lung function or health status. When services
have limited resources, prioritising patients based on levels of mastery or distress may be appropriate.
Stakeholders for this population agreed on the importance of improved access to person-centred,
multiprofessional care, and support for carers to provide or access breathlessness management
interventions. Future research should test the optimal models of care and educational strategies to address
stakeholders priorities, plus understand how to embed the core therapeutic components of these services
into routine clinical practice and health-care systems. Chronic or refractory breathlessness may serve as
useful referral indicator for timely referral and receipt of palliative care, especially in non-cancer conditions
for which poor prognostication causes unhelpful delays.
BOX 4 Reflections on PPI
Patient and public involvement member quotations
There was ample opportunity to be involved in everything and I was amazed at the scope of opportunities –
numerous and so varied. I have had experience of doing first time one-off tasks, e.g. thematic analysis on
which Lisa gave me one-to-one training. This was a major step forward in my personal development.
Margaret Ogden
[The researchers] encourage questions/explanations and are excellent mentors, helping to develop each
contributor’s learning experience.
Colleen Ewart
The collaborative approach and feeling a valued member of the team and not a ‘bottom on a seat for
box-ticking purposes’ brings its own rewards and satisfaction to all team members, including PPI members.
Sylvia Bailey
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Appendix 1 The MEDLINE search strategy
Reproduced with permission from Brighton et al.92 This is an open access article distributed inaccordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits
others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the
original work is properly cited, a link to the licence is given, and indication of whether changes were
made. See: https://creativecommons.org/licenses/by/4.0/.
MEDLINE (via OvidSP)
Date range searched: inception to 2 June 2017.
Date searched: 2 June 2017.
Search strategy
1. exp Palliative Care/
2. exp Terminal Care/
3. exp Terminally Ill/
4. exp Hospices/
5. ((advanc* or progressiv* or agressiv* or end) adj2 (diagnos* or diseas* or illnes* or cancer* or
malignan* or stage* or dementia* or failure* or heart*)).tw.
6. (last adj3 life).tw.
7. (Advanced disease or Cancer or Intrathoracic malignancy or Lung cancer or Chronic obstructive
pulmonary disease or Non-malignant disease).tw.
8. 1 or 2 or 3 or 4 or 5 or 6 or 7
9. exp nursing/
10. exp physical therapy modalities/
11. exp occupational therapy/
12. (Multiprofessional or Multidisciplinary or Holistic or Complex intervention or Non-pharmacological
intervention or non-pharmacological management or non-pharmacological or physiotherap* or Nurs*
or Occupational therap*).tw.
13. dyspn?ea.tw.
14. (short* adj2 breath).tw.
15. (urge* adj2 breath*).tw.
16. breathless*.tw.
17. ((labo?red or difficult* or small) adj3 breath*).tw.
18. ((respirat* or breath*) adj3 (distress* or comfort* or discomfort*)).tw.
19. (air adj3 (hunger or starve* or need* or gasp* or pant*)).tw.
20. suffocat*.tw.
21. unsatisf* inspiration.tw.
22. exp Dyspnea/
23. (breathlessness intervention service or breathlessness support service).tw.
24. 9 or 10 or 11 or 12
25. 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22
26. 24 and 25
27. 23 or 26
28. 8 and 27
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Appendix 2 Schedule for stakeholder workshop
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Appendix 3 The PRISMA flow chart
Records identified through
database searching
(n = 5582)
Additional records identified
through other sources
(n = 18)
Records after duplicates removed
(n = 3239)
Records screened
(n = 3239)
Records excluded
(n = 3183)
Full-text articles assessed for
eligibility
(n = 56)
Included articles in review
(n = 37)
Full-text articles excluded,
with reasons
(n = 19)
Articles included
in descriptive
synthesis
(n = 33)
Articles included
in quantitative
synthesis
(n = 11a)
Articles included
in thematic
synthesis
(n = 12)
In
cl
u
d
ed
El
ig
ib
ili
ty
Sc
re
en
in
g
Id
en
ti
fi
ca
ti
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• Intervention for diagnostic
   group, n = 7
• Intervention not holistic, n = 5
• Intervention for non-patient, n = 2
• Not patients with advanced
   disease, n = 2
• Design not eligible, n = 3
FIGURE 7 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram. a, One
article reported results from two studies. Reproduced with permission from Brighton et al.92 This is an open access
article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which
permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the
original work is properly cited, a link to the licence is given, and indication of whether changes were made.
See: https://creativecommons.org/licenses/by/4.0/.
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Appendix 4 Description of included services and
studies
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Service description Studies included in synthesis
Service Country Conditions Discipline/staff Contacts Duration Author Design
Effectiveness data Experience data
n
Quality
(%) n
Quality
(%)
aAhmadi et al.163 Canada Lung cancer Nursing
Occupational
therapy
Social work
Palliative care
(doctors)
Oncology
(doctors)
2–3 face to face
1 class
Telephone contact
for opioid follow-up
if needed
4–6 weeks
Chan et al.164 Hong
Kong
Cancer Occupational
therapy
Physiotherapy
Home-care nurses
Palliative care
(doctors, nurses)
Inpatients: daily face
to face, then 2 post
discharge
Home care: 3 face
to face, then
6 weekly if needed
≥ 1 telephone calls
4 weeks
Connors et al.101,105 UK Intrathoracic
malignancy
Palliative and
respiratory
(physiotherapist)
5 face to face 1–8 weeks Wood et al.105 Qualitative study – 9 85
Corner et al.90,98,187 UK Lung cancer or
mesothelioma
Trained nurse
research
practitioners
working
alongside
respiratory clinics
3–8 clinic visits
3 or 4 telephone
calls
8–12 weeks Corner et al.90 Mixed-methods
RCT (pilot)
34 88 20 60
Bredin et al.98 RCT 102 81 – –
aDouglas et al.170 UK Cancer and
non-cancer
Respiratory
physiotherapist
1–3 clinic visits 1–4 weeks
A
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w
w
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Service description Studies included in synthesis
Service Country Conditions Discipline/staff Contacts Duration Author Design
Effectiveness data Experience data
n
Quality
(%) n
Quality
(%)
Farquhar et al.88,91,
95,102,159,188–191
UK Cancer and
non-cancer
Occupational
therapy
Physiotherapy
Palliative care
(doctor)
Access to:
respiratory
medicine,
psychologist
2–4 home visits
3 or 4 telephone
calls
4–8 weeks Booth et al.88 Qualitative study – – 19 85
aFarquhar et al.159 Qualitative study – – Missing 40
Farquhar et al.102 Mixed-methods
before–after study
(pilot)
– – 13 45
Farquhar et al.91 Mixed-methods
RCT
67 100 20 85
Farquhar et al.95 Mixed-methods
RCT
87 100 20 80
aGoffin et al.168 Canada Intrathoracic
malignancy
Oncology (doctor)
Palliative care
(doctor)
Respiratory
(therapist, doctor)
Nursing
1 clinic visit,
follow-up needed
Hately et al.161 UK Lung cancer or
mesothelioma
Clinic run by
specialist
palliative care
physiotherapist
3 clinic visits 4–6 weeks Hately et al.161 Uncontrolled
mixed-method
study
– – 30 50
Higginson et al.94,
103,104,160,192,193
UK Cancer and
non-cancer
Physiotherapy
Occupational
therapy
Palliative care
(nurse, social
worker, doctor)
Respiratory care
(doctor)
2 clinic visits
1 home visit
3 or 4 telephone
calls
6 weeks Higginson et al.94 Mixed-methods
RCT
105 100 20 70
Gysels et al.104,160 Qualitative – – 20 80
Reilly et al.103 Cross-sectional
postal survey
– – 25 70
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Service description Studies included in synthesis
Service Country Conditions Discipline/staff Contacts Duration Author Design
Effectiveness data Experience data
n
Quality
(%) n
Quality
(%)
Johnson et al.99,158 UK Lung cancer Varied by site;
could include:
Physiotherapy
Occupational
therapy
Oncology (nurse)
Palliative care
1 face to face vs.
3 face to face
Both with 1
telephone call
2–4 weeks Barton et al.99 Feasibility RCT 22 92 – –
Johnson et al.158 RCT 156 92 – –
aKachuik and
Amjadi165
Canada Lung cancer Physician
Nurse
Occupational
therapist
Respiratory
therapist
Social worker
Above with
oncology and
palliative care
expertise
Clinic visits as
needed
aMcMahon
et al.169
Ireland Idiopathic
pulmonary
fibrosis or
COPD
Advanced nurse
practitioner led
Physiotherapist
Occupational
therapist
4–6 weeks
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Service description Studies included in synthesis
Service Country Conditions Discipline/staff Contacts Duration Author Design
Effectiveness data Experience data
n
Quality
(%) n
Quality
(%)
aPearce et al.154 UK COPD COPD nurse
Physiotherapy
Occupational
therapy
4 clinic visits 4 weeks aPearce et al.154 RCT 51 54 – –
Schunk et al.166,194 Germany Cancer and
non-cancer
Palliative care
consultants
Respiratory
physicians
Physiotherapists
Access to
psychologists,
social workers
and nurses
2 clinic visits
4 home visits
Telephone calls as
needed
6 weeks
Scullion and
Henry167
UK Lung cancer Oncology (nurse)
Physiotherapy
Occupational
therapy
Dietitian
4 group sessions 4 weeks
aUng et al.162 Canada Lung cancer Multidisciplinary
team, including a
‘clinical champion’,
tailored by local
services
Precise methodology
left to individual
cancer centres
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Service description Studies included in synthesis
Service Country Conditions Discipline/staff Contacts Duration Author Design
Effectiveness data Experience data
n
Quality
(%) n
Quality
(%)
aYates et al.155,156 Australia Lung cancer Nurse led 4 face to face or
telephone
4 weeks aYates et al.156 Quasi-experimental
(pilot) and RCT
(pilot)
30 and
57
35 and
46
– –
aYates et al.155 RCT 144 69 – –
Yorke et al.157 UK Lung cancer Specialist nurses
Physiotherapists
Complementary
therapists
2 face to face
1 telephone call
4 weeks Yorke et al.157 RCT (feasibility) 107 92 – –
a Abstract only.
Reproduced with permission from Brighton et al.92 This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which
permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of
whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
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Appendix 5 Outcomes measured in controlled
studies
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Outcomes
Study
Total
Barton
et al.99
Bredin
et al.98
Corner
et al.90
Farquhar
et al.91
Farquhar
et al.95
Higginson
et al.94
Johnson
et al.158
aPearce
et al.154
aYates et al.156
(quasi-
experimental)
aYates
et al.156 (RCT)
aYates
et al.155
Yorke
et al.157
Breathlessness
Intensity
(best/worst/average)
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ 10
Distress ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ 10
Mastery ✗ ✗ ✗ ✗ ✗ 5
Other symptoms
Anxiety/depression ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ 9
Cough ✗ 1
Fatigue ✗ ✗ ✗ 3
General ✗ ✗ ✗ 3
Functioning ✗ ✗ ✗ ✗ ✗ 5
QoL ✗ ✗ ✗ ✗ ✗ 5
Service use ✗ ✗ ✗ ✗ ✗ 5
Survival ✗ ✗ 2
Carer distress/
burden
✗ ✗ 2
a Abstract only.
Reproduced with permission from Brighton et al.92 This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which
permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of
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Appendix 6 The QualSyst quality assessment:
quantitative
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Author
1.
Objective
2.
Design
3. Subject
selection
4. Subject
characteristics
5. Random
allocation
6. Blinding
investigators
7. Blinding
subjects 8. Outcomes
9. Sample
size
10.
Analysis
11.
Estimate
of variance
12.
Confounding 13. Results
14.
Conclusion
Total
score
(%)
Barton et al.99 Yes Yes Yes Yes Yes No NA Yes Yes Yes Yes Yes Yes Yes 92
Bredin et al.98 Yes Yes Partial Yes Yes No NA Yes Yes Partial Yes Yes Yes Partial 81
Corner et al.90 Yes Yes Yes Yes Partial No NA Yes Yes Yes Yes Yes Yes Yes 88
Farquhar et al.91 Yes Yes Yes Yes Yes Yes NA Yes Yes Yes Yes Yes Yes Yes 100
Farquhar et al.95 Yes Yes Yes Yes Yes Yes NA Yes Yes Yes Yes Yes Yes Yes 100
Higginson et al.94 Yes Yes Yes Yes Yes Yes NA Yes Yes Yes Yes Yes Yes Yes 100
Johnson et al.158 Yes Yes Yes Yes Yes No NA Yes Yes Yes Yes Yes Yes Yes 92
aPearce et al.154 Partial Yes No No Partial No NA Yes Partial Partial Yes Partial Partial Yes 54
aYates et al.156
Quasi-experimental
study
Yes Yes No No No No NA No Partial Partial No No Partial Yes 35
RCT Yes Yes No No Partial No NA No Partial Partial No Yes Partial Yes 46
aYates et al.155 Yes Yes Partial Partial Partial No NA Partial Yes Partial Yes Yes Partial Yes 69
Yorke et al.157 Yes Yes Yes Yes Yes No NA Yes Yes Yes Yes Yes Yes Yes 92
NA, not applicable.
a Abstract only.
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Appendix 7 Risk of bias
Reproduced with permission from Brighton et al.92 This is an open access article distributed inaccordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits
others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the
original work is properly cited, a link to the licence is given, and indication of whether changes were
made. See: https://creativecommons.org/licenses/by/4.0/.
Barton et al. 201099
Bredin et al. 199998
Corner et al. 199690
Farquhar et al. 201491
Farquhar et al. 201695
Higginson et al. 201494
Johnson et al. 20159
Pearce et al. 2006154
Yates et al. 2007 (trial 1)156
Yates et al. 2007 (trial 2)156
Yates et al. 2011155
Yorke et al. 2015157
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Appendix 8 The QualSyst quality assessment:
qualitative
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Author
1.
Objective
2.
Design
3.
Context
4. Connection
to literature
5.
Sampling
6. Data
collection
7.
Analysis
8.
Credibility
9.
Conclusions
10.
Reflexivity
Total
score (%)
Booth et al.88 Partial Yes Yes Yes Yes Yes Yes Yes Yes No 84
Corner et al.90 Yes Yes Yes Yes Yes No No No Yes No 60
Farquhar et al.91 Yes Yes Yes Partial Yes Yes Yes Yes Yes No 85
Farquhar et al.95 Yes Yes Yes Yes Yes Yes Yes No Yes No 80
aFarquhar et al.159 Yes Yes Partial Partial No Partial No No Partial No 40
Farquhar et al.102 Partial Partial Yes Yes Partial No No No Yes No 45
Gysels et al.104,160 Yes Yes Yes Yes Yes Yes Yes No Yes No 80
Hately et al.161 Partial Yes Yes Partial Partial Partial Partial No Partial No 50
Higginson et al.94 No Partial Yes Partial Yes Yes Yes Yes Yes No 70
Reilly et al.103 Yes Partial Yes Yes Yes Yes Partial No Yes No 70
Wood et al.105 Yes Yes Yes Yes Partial Yes Yes Yes Yes No 85
a Abstract only.
Reproduced with permission from Brighton et al.92 This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which
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Appendix 9 Mixed-methods quality assessment
Study
Appropriate
mixed-methods
design
Relevant integration
of qualitative and
quantitative data
Considers limitations
of integration
(e.g. divergence) Total score (%)
Corner et al.90 Yes No No 33
Farquhar et al.91 Yes Yes No 67
Farquhar et al.95 Yes Yes Yes 100
Higginson et al.94 Yes Yes No 67
Farquhar et al.102 Yes Yes No 67
Hately et al.161 Yes Yes Yes 100
Reilly et al.103 Yes Yes No 67
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Appendix 10 Quality assessment of economic
evaluations
Item
Farquhar
et al.91
Farquhar
et al.95
Higginson
et al.94
Johnson
et al.158
1. The research question is stated ✓ ✓ ✓ ✓
2. The economic importance of the research question is stated ✓ ✓ ✓
3. The viewpoint(s) of the analysis are clearly stated and justified ? ?
4. The rationale for choosing the alternative programmes or
interventions compared is stated
✓ ✓ ✓ ✓
5. The alternatives being compared are clearly described ✓ ✓ ✓ ✓
6. The form of economic evaluation used is stated ✓ ✓ ✓ ✓
7. The choice of form of economic evaluation is justified in relation
to the questions addressed
8. The source(s) of effectiveness estimates used are stated ✓ ✓ ✓ ✓
9. Details of the design and results of effectiveness study are given ✓ ✓ ✓ ✓
10. The primary outcome measure(s) for the economic evaluation are
clearly stated
✓ ✓ ✓ ✓
11. Methods to value health states and other benefits are stated ✓ ✓ ✓ ✓
12. Details of the subjects from whom valuations were obtained are
given
✓ ✓ ✓ ✓
13. Productivity changes (if included) are reported separately NA NA NA
14. The relevance of productivity changes to the study question is
discussed
15. Quantities of resources are reported separately from their unit
costs
✓ ✓ ✓
16. Methods for the estimation of quantities and unit costs are
described
✓ ✓ ✓ ?
17. Currency and price data are recorded ✓ ✓ ✓
18. Details of currency of price adjustments for inflation or currency
conversion are given
✓
19. Details of any model used are given NA NA NA NA
20. The choice of model used and the key parameters on which it is
based are justified
NA NA NA NA
21. Time horizon of costs and benefits is stated ✓ ✓ ✓ ✓
22. The discount rate(s) is stated NA NA NA NA
23. The choice of rate(s) is justified NA NA NA NA
24. An explanation is given if costs or benefits are not discounted NA NA
25. Details of statistical tests and confidence intervals are given for
stochastic data
? ✓ ?
26. The approach to sensitivity analysis is given ✓ NA NA ✓
27. The choice of variables for sensitivity analysis is justified NA NA ✓
28. The ranges over which the variables are varied are stated NA NA ✓
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Item
Farquhar
et al.91
Farquhar
et al.95
Higginson
et al.94
Johnson
et al.158
29. Relevant alternatives are compared ✓ ✓ ✓ ✓
30. Incremental analysis is reported ✓ ✓
31. Major outcomes are presented in a disaggregated as well as
aggregated form
✓ ✓ ✓
32. The answer to the study question is given ✓ ✓ ✓ ✓
33. Conclusions follow from the data reported ✓ ✓ ✓ ✓
34. Conclusions are accompanied by the appropriate caveats ✓ ✓ ✓ ✓
Total score (%) 72 77 77 64
NA, not applicable.
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Appendix 11 Reporting quality
The PRISMA checklist (for randomised controlled trials)
Item
Bredin
et al.98
aFarquhar
et al.91
aFarquhar
et al.95
aHigginson
et al.94
Johnson
et al.158
1a Identification as RCT in title ✓ ✓ ✓ ✓ ✓
1b Structured summary ✓ ✓ ✓ ✓ ✓
2a Rationale ✓ ✓ ✓ ✓ ✓
2b Specific objectives/hypotheses ✓ ✓ ✓ ✓ ✓
3a Description of trial design ✓ ✓ ✓ ✓
3b Important changes to methods ✓ ✓
4a Eligibility criteria for participants ✓ ✓ ✓ ✓ ✓
4b Settings/locations where the data were collected ✓ ✓ ✓ ✓
5 The interventions for each group ✓ ✓ ✓ ✓
6a Defined primary and secondary outcome measures ✓ ✓ ✓ ✓
6b Any changes to trial outcomes ✓
7a How sample size was determined ✓ ✓ ✓ ✓ ✓
7b Interim analyses and stopping guidelines
8a Method used to generate the random allocation ✓ ✓ ✓ ✓
8b Type of randomisation ✓ ✓ ✓ ✓
9 Mechanism used to implement random allocation ✓ ✓ ✓
10 Who generated the random allocation, enrolled
participants, assigned participants to interventions
✓ ✓ ✓ ✓ ✓
11a If done, who was blinded ✓ ✓ ✓ ✓
11b If relevant, description of the similarity of
interventions
✓ ✓ ✓
12a Statistical methods used ✓ ✓ ✓ ✓ ✓
12b Methods for additional analyses ✓ ✓ ✓ ✓ ✓
13a Numbers of participants randomly assigned,
received intended treatment, and analysed
✓ ✓ ✓ ✓ ✓
13b Losses and exclusions after randomisation, ✓ ✓ ✓ ✓ ✓
14a Dates defining the periods of recruitment and
follow-up
✓ ✓ ✓ ✓
14b Why the trial ended or was stopped
15 A table showing baseline characteristics ✓ ✓ ✓ ✓ ✓
16 Number of participants included in each analysis ✓ ✓ ✓ ✓ ✓
17a Estimated effect size and its precision ✓ ✓ ✓ ✓ ✓
17b For binary outcomes, absolute and relative effect
sizes
NA NA NA NA
18 Results of any other analyses performed ✓ ✓ ✓ ✓ ✓
19 All important harms or unintended effects in each
group
✓ ✓
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Item
Bredin
et al.98
aFarquhar
et al.91
aFarquhar
et al.95
aHigginson
et al.94
Johnson
et al.158
20 Trial limitations ✓ ✓ ✓ ✓ ✓
21 Generalisability ✓ ✓
22 Interpretation consistent with results ✓ ✓ ✓ ✓ ✓
23 Registration number and name of trial registry ✓ ✓ ✓ ✓
24 Where the full trial protocol can be accessed ✓ ✓ ✓
25 Sources of funding and other support ✓ ✓ ✓ ✓ ✓
Checklist items reported (%) 53 81 78 92 89
NA, not applicable.
a Mixed-methods study.
Modified PRISMA checklist (for quasi-experimental studies)
Item
Chan
et al.164
Connors
et al.101
aFarquhar
et al.102
aHately
et al.161
1b Structured summary ✓ ✓
2a Rationale ✓ ✓ ✓ ✓
2b Specific objectives/hypotheses
3a Description of trial design ✓ ✓
3b Important changes to methods NA
4a Eligibility criteria for participants ✓ ✓ ✓ ✓
4b Settings/locations where the data were collected ✓ ✓
5 The interventions for each group ✓ ✓
6a Defined primary and secondary outcome measures ✓
6b Any changes to trial outcomes NA
7a How sample size was determined ✓
7b Interim analyses and stopping guidelines NA
11a If done, who was blinded NA NA NA NA
11b If relevant, description of the similarity of interventions NA NA NA NA
12a Statistical methods used NA NA ✓
12b Methods for additional analyses NA NA NA NA
13a Numbers of participants randomly assigned, received intended
treatment, and analysed
NA ✓ ✓ ✓
13b Losses and exclusions NA ✓ ✓ ✓
14a Dates defining the periods of recruitment and follow-up ✓ ✓
14b Why the trial ended or was stopped NA ✓
15 A table showing baseline characteristics ✓ ✓ ✓
16 Number of participants included in each analysis ✓ ✓ ✓ ✓
17a Estimated effect size and its precision ✓ ✓ ✓ ✓
17b For binary outcomes, absolute and relative effect sizes NA NA NA NA
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Item
Chan
et al.164
Connors
et al.101
aFarquhar
et al.102
aHately
et al.161
18 Results of any other analyses performed NA NA NA NA
19 All important harms or unintended effects in each group
20 Trial limitations ✓ ✓
21 Generalisability ✓ ✓
22 Interpretation consistent with results ✓ ✓ ✓
23 Registration number and name of trial registry NA ✓
24 Where the full trial protocol can be accessed NA ✓
25 Sources of funding and other support ✓ ✓ ✓
Checklist items reported (%) 63 35 73 41
NA, not applicable.
a Mixed-methods study.
The PRISMA checklist (for pilot and feasibility studies)
Item
aCorner
et al.90
Farquhar
et al.190
Barton
et al.99
Yorke
et al.157
1a Identification as a pilot or feasibility trial ✓ ✓ ✓
1b Structured summary ✓ ✓ ✓ ✓
2a Rationale ✓ ✓ ✓ ✓
2b Specific objectives/research questions ✓ ✓ ✓
3a Description of pilot trial design ✓ ✓ ✓
3b Important changes to methods ✓ ✓
4a Eligibility criteria for participants ✓ ✓ ✓ ✓
4b Settings and locations where the data were collected ✓ ✓
4c How participants were identified and consented ✓ ✓
5 The interventions for each group ✓ ✓ ✓ ✓
6a Defined assessments to address each objective ✓
6b Any changes to assessments ✓
6c Prespecified criteria used to judge whether/how, to proceed with
future definitive trial
7a Rationale for numbers in the pilot trial ✓ ✓ ✓
8a Method used to generate the random allocation ✓ ✓
8b Type of randomisation ✓ ✓ ✓
9 Mechanism used to implement the random allocation ✓ ✓
10 Who generated the random allocation, enrolled participants,
assigned participants to interventions
✓ ✓ ✓
11a If done, who was blinded ✓ ✓ NA
11b If relevant, description of the similarity of interventions ✓ ✓ ✓
12 Methods used to address each objective ✓
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Item
aCorner
et al.90
Farquhar
et al.190
Barton
et al.99
Yorke
et al.157
13a Numbers of participants randomly assigned, received intended
treatment, and analysed
✓ ✓ ✓
13b Losses and exclusions after randomisation ✓ ✓ ✓ ✓
14a Dates defining the periods of recruitment and follow-up ✓ ✓ ✓
14b Why the pilot trial ended or was stopped ✓
15 A table showing baseline characteristics ✓ ✓ ✓ ✓
16 Number of participants included in each analysis ✓ ✓ ✓ ✓
17 Results including expressions of uncertainty ✓ NA ✓ ✓
18 Results of any other analyses ✓ ✓ ✓
19 All important harms or unintended effects in each group
19a Other important unintended consequences
20 Pilot trial limitations ✓ ✓
21 Generalisability ✓
22 Interpretation consistent with objectives and findings ✓ ✓ ✓ ✓
22a Implications for progression from pilot to future definitive trial,
including any proposed amendments
✓ ✓ ✓ ✓
23 Registration number and name of trial registry ✓ ✓
24 Where the pilot trial protocol can be accessed
25 Sources of funding and other support ✓ ✓ ✓ ✓
26 Ethics approval ✓ ✓ ✓
Checklist item reported (%) 31 79 74 68
NA, not applicable.
a Mixed-methods study.
The STROBE checklist (for observational studies)
Item aReilly et al.103
1 (a) Indicate the study’s design
1 (b) Provide in the abstract an informative and balanced summary ✓
2 Explain the rationale ✓
3 State specific objectives/hypotheses ✓
4 Present key elements of study design ✓
5 Describe the setting, locations, and relevant dates ✓
6 (a) Eligibility criteria, sources and selection of participants ✓
6 (b) For matched studies, give matching criteria NA
7 Define outcomes, exposures, predictors, confounders, modifiers ✓
8 Give sources of data and details of methods of assessment ✓
9 Describe any efforts to address potential sources of bias
10 Explain how the study size was arrived at ✓
APPENDIX 11
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Item aReilly et al.103
11 Explain how variables were handled in the analyses ✓
12 (a) Describe all statistical methods ✓
12 (b) Describe methods used to examine subgroups/interactions NA
12 (c) Explain how missing data were addressed
12 (d) Explain how loss to follow-up/matching was addressed NA
12 (e) Describe any sensitivity analyses NA
13 (a) Report numbers of individuals at each stage of study ✓
13 (b) Give reasons for non-participation at each stage ✓
13 (c) Consider use of a flow diagram
14 (a) Give characteristics of study participants ✓
14 (b) Indicate number of participants with missing data ✓
14 (c) Summarise follow-up time NA
15 Outcome data: numbers of outcome events/summary measures ✓
16 (a) Give unadjusted and adjusted estimates and their precision NA
16 (b) Report category boundaries for grouped continuous variables NA
16 (c) Consider translating relative risk into absolute risk NA
17 Report other analyses done NA
18 Summarise key results with reference to study objectives ✓
19 Discuss limitations of the study ✓
20 Give a cautious overall interpretation of results ✓
21 Discuss the generalisability of the study results ✓
22 Give the source of funding and the role of the funders ✓
Checklist items reported (%) 84
NA, not applicable.
a Mixed-methods study.
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The COREQ checklist (for qualitative studies)
Item
aCorner
et al.90
aFarquhar
et al.91
aFarquhar
et al.95
aHigginson
et al.94
aFarquhar
et al.102
Gysels
et al.160
aHately
et al.161
aReilly
et al.103
Wood
et al.105
Booth
et al.88
Which author/s conducted the interview/focus group ✓ ✓ NA ✓
Researcher’s credentials NA
Researcher occupation at the time of the study ✓ ✓ ✓ NA ✓
Researcher gender NA ✓
Experience or training of the researcher ✓ ✓ ✓ NA
Whether a relationship was established prior to study ✓ NA
What participants knew about the researcher NA
Characteristics of the interviewer/facilitator NA
Methodological orientation ✓ ✓ ✓ ✓ ✓ ✓
How participants were selected ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
How participants were approached ✓ ✓ ✓ ✓ ✓ ✓ ✓
How many participants there were in the study ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
How many people refused to participate/dropped out ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Where the data was collected ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Whether anyone else was present NA ✓
Important characteristics of the sample ✓ ✓ ✓ ✓ ✓ ✓
Whether questions, prompts, guides were provided ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Whether repeat interviews carried out ✓ ✓ ✓ ✓ ✓ ✓ NA ✓
Whether they used audio or visual recording ✓ ✓ ✓ ✓ ✓ NA ✓ ✓
Whether field notes were made ✓ ✓ NA
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Item
aCorner
et al.90
aFarquhar
et al.91
aFarquhar
et al.95
aHigginson
et al.94
aFarquhar
et al.102
Gysels
et al.160
aHately
et al.161
aReilly
et al.103
Wood
et al.105
Booth
et al.88
Duration of the interviews or focus group NA
Data saturation discussed ✓
Whether transcripts were returned for comment NA
How many data coders coded the data ✓ ✓ ✓
Description of the coding tree ✓
Themes identified in advance or derived from the data ✓ ✓ ✓ ✓ ✓ ✓
Software used to manage the data ✓ ✓ ✓ ✓ ✓ ✓ ✓
Whether participants provided feedback on the findings ✓
Identified participant quotations to illustrate findings ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Consistency between the data presented and findings ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Major themes clearly presented in the findings ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Description of diverse cases/minor themes
Checklist items reported (%) 22 50 50 41 38 41 41 68 63 50
NA, not applicable.
a Mixed-methods study.
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